Control of actin polymerization via the coincidence of phosphoinositides and high membrane curvature by Daste, F et al.
JCB
JCB: Article
T
H
E
 J
O
U
R
N
A
L
 O
F
 C
E
L
L
 B
IO
L
O
G
Y
1
The Rockefeller University Press 
J. Cell Biol.
https://doi.org/10.1083/jcb.201704061
Introduction
Actin dynamics are essential for the eukaryotic cell in providing 
a framework for organizing the membrane and producing force 
for vesicle deformation, transport of endocytic vesicles, cytoki-
nesis, and cell protrusions, among other functions. How the array 
of actin nucleators, elongators, and bundlers work together to 
orchestrate actin assembly when and where it is needed remains 
a key question (Skau and Waterman, 2015). Clathrin-mediated 
endocytosis (CME) in mammalian cells provides a striking ex-
ample of the need for regulated actin assembly.
Though it is well established that actin plays a critical role 
for endocytosis in yeast, where it drives inward invagination 
and fission of endocytic membranes (Picco et al., 2015) to-
gether with the pulling action of myosin motors (Lewellyn et 
al., 2015), in mammalian cells, the picture is more complicated. 
The degree to which actin assembly is required for CME differs 
depending on whether the clathrin-coated pits (CCPs) are bud-
ding from adherent, glass-facing membranes or nonadherent, 
media-facing areas of the cell (Yarar et al., 2005), and different 
cell types use actin to greater or lesser extents (Fujimoto et al., 
2000; Mooren et al., 2012). One explanation is that the force 
from actin polymerization is used to aid deformation and scis-
sion of the vesicle when membrane tension is high (Aghamo-
hammadzadeh and Ayscough, 2009; Ferguson et al., 2009; 
Boulant et al., 2011). How this tension might be sensed to trig-
ger actin assembly is unknown.
Actin assembly is regulated by PI(4,5)P2, the major 
signaling lipid in the inner leaflet of the plasma membrane 
(Saarikangas et al., 2010; Michelot and Drubin, 2011). During 
endocytosis, plasma membrane PI(4,5)P2 is dephosphorylated 
by the PI(4,5)P2 phosphatases, synaptojanin, and oculocerebro-
renal syndrome of Lowe (OCRL). The resulting PI(4)P product 
can be phosphorylated to PI(3,4)P2 by the class II PI 3-kinase, 
PI 3-kinase C2-α (Posor et al., 2013), and then dephosphory-
lated at position 4 by INPP4A, yielding PI(3)P, the hallmark 
of the early endosomal compartment (Shin et al., 2005). 
Thus, during the budding of endocytic vesicles, a cascade of 
The conditional use of actin during clathrin-mediated endocytosis in mammalian cells suggests that the cell controls 
whether and how actin is used. Using a combination of biochemical reconstitution and mammalian cell culture, we elu-
cidate a mechanism by which the coincidence of PI(4,5)P2 and PI(3)P in a curved vesicle triggers actin polymerization. 
At clathrin-coated pits, PI(3)P is produced by the INPP4A hydrolysis of PI(3,4)P2, and this is necessary for actin-driven 
endocytosis. Both Cdc42⋅guanosine triphosphate and SNX9 activate N-WASP–WIP- and Arp2/3-mediated actin nucle-
ation. Membrane curvature, PI(4,5)P2, and PI(3)P signals are needed for SNX9 assembly via its PX–BAR domain, 
whereas signaling through Cdc42 is activated by PI(4,5)P2 alone. INPP4A activity is stimulated by high membrane 
curvature and synergizes with SNX9 BAR domain binding in a process we call curvature cascade amplification. We 
show that the SNX9-driven actin comets that arise on human disease–associated oculocerebrorenal syndrome of Lowe 
(OCRL) deficiencies are reduced by inhibiting PI(3)P production, suggesting PI(3)P kinase inhibitors as a therapeutic 
strategy in Lowe syndrome.
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phosphatidylinositol conversion steps is proposed whereby 
sequential dephosphorylation of PI(4,5)P2 to PI(4)P by syn-
aptojanin, phosphorylation by PI 3-kinase to produce PI(3,4)
P2, and dephosphorylation ultimately form the PI(3)P signal 
characteristic of the early endosome (Fig.  1  A; Posor et al., 
2013). How these lipid kinases and phosphatases are con-
trolled to ensure proper spatial and temporal regulation of this 
cascade remains unknown.
The importance of phosphatidylinositol metabolism in 
actin organization and wider cell physiology is underscored 
Figure 1. PI(4,5)P2 and PI(3)P signal actin polymerization via SNX9. (A) Cascade of phosphoinositide lipid conversion steps during endocytosis: dephos-
phorylation of PI(4,5)P2 to PI(4)P by synaptojanin, phosphorylation by PI 3-kinase to produce PI(3,4)P2, and dephosphorylation by INPP4A to form the 
PI(3)P signal characteristic of the early endosome. (B) Schematic diagram of our cell-free assay for phosphoinositide environment in actin polymerization. 
Competitive assay that examines phosphoinositide preferences (PI(4,5)P2 + PI(3)P or PI(4,5)P2 + PI(3,4)P2) in the range of curvatures at a budding CCP. 
(C) Direct observation of liposome samples with a continuous size distribution from 50 nm to 5 µm. Rhodamine fluorescence was used for 4% PI(4,5)P2, 
1% PI(3)P, 65% PC, and 30% PS liposomes (all percentages by molecular fraction, purple) and NBD for 4% PI(4,5)P2, 1% PI(3,4)P2, 65% PC, and 30% PS 
(cyan) using spinning-disk confocal microscopy. (D) Maximal activation of actin polymerization by liposomes containing 4% PI(4,5)P2, 1% PI(3)P, 48% PC, 
and 47% PS assayed by pyrene actin assay with HSS compared with 4% PI(4,5)P2 alone or 4% PI(4,5)P2 + 1% PI(3,4)P2. Data show mean of four traces 
from two independent experiments. AU, arbitrary units. (E) As in C, except 10% PI(3,4)P2 (cyan). (F) 10% PI(3,4)P2 liposomes (cyan), extracts + SNX9. 
In all experiments, we exclusively observed the formation of comet tail at the surface of PI(4,5)P2/PI(3)P liposomes. (G) 10% PI(3,4)P2 liposomes (cyan) 
preincubated with INPP4A. Actin polymerization occurred from the cyan liposomes. Bars, 3 µm.
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by disease-causing mutations in OCRL. Deficiencies in OCRL 
cause Lowe syndrome, a multisystem genetic condition char-
acterized by congenital cataracts, intellectual disability, and 
kidney absorption problems (Bökenkamp and Ludwig, 2016). 
OCRL is recruited to CCPs at late stages of CME and remains 
associated with early endosomes (Ungewickell et al., 2004; 
Vicinanza et al., 2011). Patient-derived cells exhibit defects in 
actin organization and endocytosis, with aberrant actin assem-
bly on endosomes that rocket through the cytoplasm on actin 
comet tails (Suchy and Nussbaum, 2002; Nández et al., 2014). 
Congruent with the kidney absorption defects, cultured human 
kidney 2 and patient proximal tubule cells display reduced 
trafficking through the early endosomal pathway, resulting in 
enlarged and PI(3)P-enriched structures that accumulate actin 
(Vicinanza et al., 2011).
Both PI 3-kinases and synaptojanin are activated by high 
membrane curvature (Hübner et al., 1998; Chang-Ileto et al., 
2011). Interestingly, several actin regulators that assemble at 
CCPs, including the adapter proteins SNX9 and TOCA-1, con-
tain membrane curvature-sensing BAR domains. SNX9 and 
TOCA-1 localize to sites of CME and are also candidates for 
regulating actin during endocytosis via clustering of the nucle-
ation-promoting factor neural Wiskott-Aldrich syndrome pro-
tein (N-WASP; Lundmark and Carlsson, 2003; Ho et al., 2004; 
Itoh et al., 2005; Soulet et al., 2005; Tsujita et al., 2006; Yarar 
et al., 2007). The isolated BAR–PX domain of SNX9 binds 
preferentially to membranes of high curvature (Pylypenko 
et al., 2007), and a pathway from SNX9 to actin polymeriza-
tion has been reconstituted from purified components (Yarar 
et al., 2008). Actin polymerization downstream of TOCA-1 
is observed preferentially on larger, less curved vesicles in 
vitro, which are subsequently deformed to the desired curva-
ture. Thus, TOCA-1–mediated actin assembly drives curva-
ture rather than responding to it (Takano et al., 2008). Whether 
SNX9-mediated actin assembly is dependent on membrane cur-
vature has not been tested.
To determine how the membrane environment informs 
when and where actin is polymerized, we have dissected a path-
way from phosphatidylinositol conversions and high membrane 
curvature through to actin polymerization in endocytosis. We 
find that high membrane curvature stimulates PI(3,4)P2 dephos-
phorylation by INPP4A and that the resulting PI(3)P in turn 
recruits SNX9 in conjunction with both PI(4,5)P2 and high 
membrane curvature. This three-way coincidence detection 
integrates the mechanics, lipid signaling, and protein cascades 
of CME to ensure its efficiency. We further propose that this 
signaling cascade can function to trigger actin assembly in re-
sponse to delays in vesicle scission. Furthermore, we show that 
Lowe syndrome is a disease that mimics this membrane micro-
environment, with the aberrant formation of a PI(4,5)P2/PI(3)P 
intermediate giving rise to actin comets. We demonstrate that 
the formation of actin comets in OCRL deficiency can be alle-
viated by reducing PI(3)P levels using PI 3-kinase inhibitors, 
suggesting a possible therapeutic strategy in Lowe syndrome.
Results
PI(4,5)P2 and PI(3)P signal actin 
polymerization via SNX9
Our previous work showed that the coincidence of PI(4,5)P2, 
PI(3)P, and membrane curvature stimulates actin polymerization 
in Xenopus egg extracts in an SNX9-dependent manner (Gallop 
et al., 2013). PI(4,5)P2 is a well-known activator of Cdc42 and 
N-WASP, and in turn the Arp2/3 complex. However, SNX9 has 
previously been implicated as an effector of PI(3,4)P2 after it 
is produced by the sequential actions of synaptojanin and PI 
3-kinase C2-α (Posor et al., 2013). Therefore, to test the roles of 
PI(3,4)P2 or PI(3)P in actin polymerization within a cytoplasmic 
environment, we developed a competitive assay that examines 
phosphatidylinositol preferences in the context of high-speed 
supernatant (HSS) frog egg extracts (Fig.  1 B). HSS extracts 
provide a rich mixture of proteins necessary for early frog de-
velopment and are depleted for endogenous membranes. Vesi-
cles that contain either PI(4,5)P2 plus PI(3)P or PI(4,5)P2 plus 
PI(3,4)P2 in a phosphatidylcholine (PC) and phosphatidylserine 
(PS) background were labeled with rhodamine-phosphatidy-
lethanolamine (PE) or nitro-2-1,3-benzoxadiazol (NBD)–PE, 
respectively, as probes to distinguish the two vesicle popula-
tions (Fig. 1 B). To mimic the range of curvatures at a budding 
CCP, we prepared a continuous distribution of unilamellar ves-
icles for each lipid composition, spanning a size range from 50 
nm to 5 µm in diameter (Fig. 1 B). The vesicles were mixed and 
mounted in a microscopy chamber, and HSS extracts supple-
mented with Alexa Fluor 647–labeled actin were added, with or 
without the addition of excess recombinant SNX9. We observed 
dense accumulations of labeled actin at the vesicle surfaces that 
form actin comets, leading to vesicle motility (Fig.  1  C). In-
terestingly, comets formed exclusively from PI(4,5)P2/PI(3)P 
vesicles (Fig. 1 C, purple vesicles). Within a competitive assay 
format, it is possible that the concentrations of actin regulatory 
proteins are limited and that PI(4,5)P2/PI(3)P is simply pre-
ferred, rather than there being no activity arising from PI(3,4)P2. 
To distinguish between these possibilities and to provide an in-
dependent assay format to test the activity of PI(3,4)P2, we per-
formed pyrene actin assays with vesicles containing PI(4,5)P2 
(which is needed to activate Cdc42 and N-WASP) and PI(3)P 
or PI(3,4)P2. Consistent with the results from the competition 
assay, supplementing PI(4,5)P2-containing vesicles with PI(3)P 
resulted in a substantial increase in both the rate and extent of 
actin polymerization, whereas the presence of PI(3,4)P2 re-
producibly inhibited actin polymerization (Fig.  1  D). The in-
hibitory effect could be caused by PI(3,4)P2-binding proteins 
within the HSS occluding PI(4,5)P2-binding sites, thereby in-
hibiting N-WASP or Cdc42 activation. However, the presence 
of PI(3,4)P2 did not inhibit actin polymerization from PI(3)P/
PI(4,5)P2-containing vesicles (Fig. 1 D).
Even upon incorporation of 10% PI(3,4)P2 and with addi-
tional SNX9, actin comets failed to form on vesicles containing 
PI(3,4)P2 (Fig. 1, E and F, cyan vesicles; >250 liposomes were 
analyzed for each condition). Interestingly, when excess SNX9 
was added, the actin comets appeared to form preferentially on 
the small liposomes and always on those containing PI(4,5)P2 
and PI(3)P (Fig. 1 F, purple vesicles).
Our in vitro findings are inconsistent with previous in vivo 
data suggesting that SNX9 is recruited to CCPs via its interac-
tions with PI(3,4)P2 (Posor et al., 2013). To reconcile these dif-
ferences, we considered that although PI(3,4)P2 is not a direct 
upstream signal for actin polymerization by SNX9 in our model 
system, it could be a substrate for the production of PI(3)P via 
the action of INPP4A. To test this possibility, and also to con-
firm the integrity of our PI(3,4)P2, we repeated the previous ex-
periment and included a preincubation of PI(3,4)P2-containing 
liposomes with recombinant INPP4A, which may be limiting 
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in our HSS. Confirming our hypothesis, actin comet tails then 
arose from both sets of vesicles that originally contained either 
PI(3)P or PI(3,4)P2 (Fig. 1 G). Therefore, rather than PI(3,4)P2 
being a direct agonist of SNX9 (Posor et al., 2013) for actin 
polymerization, we show that PI(3,4)P2 hydrolysis provides a 
source of PI(3)P.  Together, these data establish that SNX9 is 
preferentially recruited to liposomes bearing PI(4,5)P2 and 
PI(3)P where it triggers actin assembly.
Identifying the minimum machinery required 
for SNX9-regulated actin assembly
We previously identified SNX9, Cdc42⋅GTP-γS, and N-WASP 
as components necessary for PI(4,5)P2/PI(3)P-triggered actin 
polymerization (Gallop et al., 2013). To determine whether 
these factors were sufficient, we reconstituted the pathway from 
purified components. SNX9, Cdc42⋅GTP-γS, N-WASP (pu-
rified in its physiological complex with Wiskott-Aldrich syn-
drome–interacting protein [WIP], which is thought to be a more 
autoinhibted form; Ho et al., 2004), the Arp2/3 complex, and 
actin were mixed, and actin polymerization was measured using 
either a pyrene actin assay to quantify the rate of actin polym-
erization or a microscopy assay to directly visualize actin struc-
tures. In a pyrene actin assay, significant actin polymerization 
was only observed on vesicles containing both PI(4,5)P2 and 
PI(3)P (Fig. 2, A and B; protein purifications are shown in Fig. 
S1, A–E). The GST-VCA domain of N-WASP, which triggers 
Arp2/3 complex–mediated actin polymerization independently 
of Cdc42⋅GTP or BAR domain adapter protein regulation, was 
used as the positive control (Fig. 2 A). Unlike previous reconsti-
tutions with SNX9 that used N-WASP alone (Yarar et al., 2008), 
Cdc42 was required under our assay conditions (Fig. 2 B), likely 
because of the use of the N-WASP–WIP complex. To confirm 
these findings, we visualized the polymerization of actin directly 
at the membrane surface via confocal imaging of PI(4,5)P2 plus 
PI(3)P vesicles (in a PC/PS background with rhodamine-PE as 
a probe) together with all purified components and Alexa Fluor 
647–actin. The polymerization of actin over time was detected 
by the dense accumulation of labeled actin at the vesicle sur-
faces (Fig. 2 C). We also confirmed that Cdc42 must be in the 
GTP-bound state (Fig. 2 D), and we visualized F-actin by EM, 
showing the disordered nature of the actin consistent with a 
highly branched Arp2/3 complex–generated network (Fig. 2 E). 
Finally, conducting microscopy experiments in the absence of 
each individual component confirmed that (a) Cdc42 is essen-
tial and that (b) removal of any other component also abolishes 
actin polymerization (Fig. 2, F–I). Thus, PI(4,5)P2, PI(3)P, Cd-
c42⋅GTP, N-WASP–WIP, Arp2/3 complex, and SNX9 are nec-
essary and sufficient to trigger actin polymerization.
Synergistic binding of two phosphoinositide 
lipids by SNX9 subfamily PX–BAR domains
SNX9 has previously been shown to bind promiscuously to a 
variety of phosphoinositide lipids (Pylypenko et al., 2007; Yarar 
et al., 2008), each assayed independently. To look in more detail 
at the apparently synergistic binding of two phosphoinositide 
lipids, we probed the role of the adjacent BAR and PX domains 
in determining the ability of SNX9 to detect the coincidence 
of PI(4,5)P2 and PI(3)P. By aligning Xenopus sequences with 
the existing crystal structure (Fig. 3 A; Pylypenko et al., 2007), 
we generated mutants in the proposed lipid-binding sites within 
the PX and BAR domains of Xenopus SNX9 and compared 
their lipid-binding specificities with the WT protein (Fig. 3 B). 
Two mutants were generated: K511E/K517E (Xenopus residue 
numbers), which make up a positively charged patch within the 
SNX9 BAR domain, and Y276A/K302A, which is present in 
the phosphoinositide lipid–binding pocket within the PX do-
main (Fig. 3 A). We first examined the binding of these mutants 
to PI(3)P-containing liposomes compared with WT protein 
(Fig.  3  B). The weak binding observed with WT SNX9 was 
reduced to background levels seen with PC/PS liposomes by 
either of the mutations (Fig. 3 B). Thus, both the PX and BAR 
domains contribute to weak PI(3)P binding with no apparent 
synergy. As previously reported for mammalian SNX9 (Py-
lypenko et al., 2007; Yarar et al., 2008), Xenopus SNX9 bound 
more strongly to PI(4,5)P2-containing liposomes. Interestingly, 
this binding was unaffected by the PX domain mutation but 
was markedly inhibited by the BAR domain mutation. When 
PI(4,5)P2 and PI(3)P were presented together, the membrane–
protein interaction was of substantially higher affinity, and then 
both the PX phosphoinositide lipid–binding pocket and the 
BAR domain made significant contributions to the interaction 
(Fig. 3 B; gels are shown in Fig. S2 A). These data thus support 
a model in which the PX–BAR domain encodes a dual speci-
ficity phosphoinositide lipid–binding module that enables the 
coincident detection of two phosphoinositide lipids.
SNX9 is a member of a subfamily of closely related sort-
ing nexins that includes SNX18 and 33 (Carlton et al., 2005), 
as well as a larger family that encodes PX–BAR domains 
(Worby and Dixon, 2002), but lacks the SH3 domain. These 
include SNX2, 4, 5, and 8, which function in trafficking from 
the early endosome to the TGN, plasma membrane, or late en-
dosome (Fig. 3 C). To determine whether synergistic binding to 
two lipid species was a unique property of the SNX9 subfamily, 
or rather of all PX–BAR modules, we expressed these proteins 
and examined their liposome-binding properties (Fig. 3 D and 
Fig. S2 B). Though all the SNX PX–BARs interact with the 
membranes used, we could not detect specific double phospho-
inositide selectivity testing against likely lipid combinations 
implied by their involvement in trafficking from endosomes 
(Fig. 3 C). In contrast, sedimentation assays and Western blot-
ting for SNX18 and 33 showed that these SNX9 subfamily 
members also preferentially bound to liposomes containing 
both PI(4,5)P2 and PI(3)P (Fig. 3 E and Fig. S2 C). We verified 
these results using flotation assays instead of the sedimentation 
assay (Fig. S2, D and E). Although we have not tested all pos-
sible combinations of phosphoinositide lipids, our assays using 
the most likely combinations indicate that dual phosphoinosit-
ide lipid binding is likely a property unique to the SNX9, 18, 
and 33 subfamily of PX-BARs.
Membrane curvature–dependent SNX9 
binding and INPP4A activity combine to 
regulate actin polymerization
The BAR–PX domain of SNX9 has previously been reported 
to preferentially bind smaller, highly curved liposomes via 
the curvature of the BAR domain and the insertion of an am-
phipathic helix (Pylypenko et al., 2007). Consistent with this, 
we previously observed SNX9-dependent, curvature-sensitive 
actin polymerization on PI(4,5)P2/PI(3)P liposomes (Gallop 
et al., 2013). Close examination of the microscopy images in 
Fig. 1 suggested that, compared with extracts alone, there was a 
drive toward actin polymerization from small, diffraction-lim-
ited vesicles both when SNX9 was added and after hydrolysis 
of PI(3,4)P2 by INPP4A (Fig. 1, compare E with F and G). We 
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therefore explored this phenomenon further to better define the 
mechanism for membrane curvature sensing in the PI(4,5)P2/
PI(3)P pathway of actin polymerization.
To measure the preference of SNX9 for binding small 
PI(4,5)P2/PI(3)P liposomes, we generated 100- or 250-nm 
mean diameter liposomes and used superresolution microscopy 
to directly measure their underlying size distribution. Lipo-
somes were superresolved with point accumulation for imag-
ing nanoscale topology (PAI NT) microscopy using Nile red, 
and their individual diameters were measured by fitting with a 
Figure 2. Identifying the minimal machinery required for SNX9-regulated actin assembly. (A) Maximal activation of actin polymerization by liposomes 
containing 4% PI(4,5)P2 + 1% PI(3)P (with 48% PC and 47% PS) assayed by pyrene actin assay in the minimal reconstituted system (20 nM Arp2/3 
complex, 500 nM Cdc42⋅GTP-γS, 100 nM N-WASP/WIP complex, 100 nM SNX9, and 1 µM actin, 65:35 pyrene actin) compared with 4% PI(4,5)P2 
alone, actin alone, and activation by GST-VCA fragment from N-WASP as a positive control. Data show the mean of eight traces. AU, arbitrary units. 
(B) Maximal rates from two technical repeats each of four independent experiments showing the mean and SEM. The maximal rates were normalized 
against 100% activation by GST-VCA. Significance was tested using an ANO VA test with a Tukey's multiple comparison post-hoc test; actin versus PI(4,5)P2: 
P = 0.900; actin versus PI(4,5)P2/PI(3)P: ***, P = 0.001; actin versus −Cdc42: P = 0.9000. ns, not significant. (C) Direct observation of liposomes (4% 
PI(4,5)P2, 1% PI(3)P, 65% PC, 30% PS; purple) in the presence of the minimal purified system containing 50 nM Arp2/3 complex, 50 nM Cdc42⋅GTP-γS, 
100 nM N-WASP–WIP complex, 100 nM SNX9, 8 µM unlabeled actin, and 0.3 µM Alexa Fluor 647–labeled actin. Actin asters form at the surface of 
highly curved liposomes only when all components are present. (D) Activation of Cdc42 is needed. Direct observation of liposome samples with a contin-
uous size distribution from 50 nm to 5 µm (4% PI(4,5)P2, 1% PI(3)P, 65% PC, 30% PS; purple) in the presence of the minimal purified system containing 
Cdc42⋅GDP. (C and D) Bars, 3 µm. (E) Electron micrograph of actin asters after incubation of PI(4,5)P2/PI(3)P liposomes with the minimal purified system 
shows disordered and branched actin filaments. Bar, 100 nm. (F–I) All components of the purified system are required for efficient actin polymerization. 
No actin polymerization is seen with the minimal purified system minus each individual component: Cdc42⋅GTP-γS (F), SNX9 (G), N-WASP–WIP (H), or 
Arp2/3 complex (I). Bars, 6 µm.
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Figure 3. A unique property of SNX9 subfamily in binding two phosphoinositides using two adjacent lipid-binding domains. (A) Mutations in the various 
proposed lipid-binding sites within the PX and BAR domains of Xenopus SNX9. K511E/K517E, which are residues that make up a positively charged 
patch within the SNX9 BAR domain, and Y276A/K302A, which is the phosphoinositide lipid–binding pocket within the PX domain. The structure shown 
is 2RAI, downloaded from the Protein Data Bank and visualized in the CCP4mg molecular graphics package with the Xenopus numbering inferred from a 
sequence alignment performed in Lasergene software. (B) The liposome compositions used were 5% PI(4,5)P2, 5% PI(3)P, or 4% PI(4,5)P2/1% PI(3)P with 
65% PC and 30% PS. Mutagenesis shows that binding of SNX9 to 100-nm PI(4,5)P2 liposomes is driven by positively charged patches on the BAR domain 
binding to PI(4,5)P2. The pocket on the PX domain is important for binding PI(4,5)P2 and PI(3)P. Data are the mean of three independent liposome batches 
and sedimentation assays. One-way ANO VA between mutants is not significant for PI(3)P: P = 0.0594. One-way ANO VA between mutants is significant for 
PI(4,5)P2: P = 0.0133; and PI(4,5)P2/PI(3)P: P = 9.25 × 10−5. By post-hoc Tukey's honest significant difference (HSD) test, the difference between WT and 
Y276A/K302A for PI(4,5)P2/PI(3)P: **, P = 0.00223; for PI(4,5)P2: P = 0.864; and for PI(3)P: P = 0.0730. For the WT compared with K511E/K517E 
mutant with PI(4,5)P2/PI(3)P: **, P = 0.00101; for PI(4,5)P2: *, P = 0.0161; and for PI(3)P: P = 0.098. (C) Phosphoinositides and SNX-BAR proteins in the 
endosomal network. Schematic diagram showing putative double phosphoinositide compositions for trafficking between compartments where SNX PX–BAR 
domains are implicated. (D) Sedimentation assay of SNX2, 4, 5, or 8 on liposomes that contain various double phosphoinositide lipid compositions. The 
liposome compositions were 5% of each phosphoinositide with 65% PC and 30% or 25% PS. Data are the mean of three independent liposome batches 
and sedimentation assays. No binding is above background suggesting that double phosphoinositide binding is a property specific to the SNX9 subfamily. 
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two-dimensional Gaussian function (Fig. 4, A and B; Sharonov 
and Hochstrasser, 2006). By measuring the liposomes one by 
one, it is possible to directly extract both the entire size distribu-
tion and total membrane area from a liposome count (under the 
assumption that the liposomes are spherical; Fig. S3, A and B). 
Dynamic light-scattering data indicate a slightly larger size, as 
expected from the disproportionate effect of larger vesicles to the 
scattering (Fig. S3 D). To determine a binding curve, PI(4,5)P2/ 
PI(3)P liposomes of each size distribution were incubated with 
increasing concentrations of SNX9, and the fraction of lipo-
somes with SNX9 bound was counted by two-color confocal 
imaging (between 152 and 518 liposomes were counted for 
each condition; Fig. 4, A–C). Though measuring number alone 
shows some effect of curvature, saturating at 50% of liposomes 
bound for 100 nm and 35% bound for 250 nm (i.e., there are 
more binding sites for SNX9 present on more highly curved 
surfaces), the key measure is actually the surface area of mem-
brane presented to a given concentration of SNX9. Because the 
more highly curved liposomes are smaller, less surface area of 
membrane is present per liposome compared with less curved 
ones. To adjust for this, we calculated the surface area of mem-
brane provided by the numbers of 100- or 250-nm liposomes 
recorded from the confocal images based on the size distribu-
tions measured by PAI NT microscopy (Fig. 4 A and Fig. S3). 
The SNX9 binding curve reveals an ∼10-fold increase in SNX9 
binding per surface area on small liposomes (Fig. 4 C).
INPP4A is predicted to contain a double C2 domain (Ivetac 
et al., 2005), which is known to confer curvature sensitivity in 
synaptotagmin (Martens et al., 2007). We therefore assessed 
whether INPP4A activity exhibited curvature sensitivity. As 
shown in Fig. 4 D, the rate of hydrolysis of PI(3,4)P2 to PI(3)P 
by recombinant INPP4A was approximately twofold faster for 
100-nm liposomes as compared with 250-nm liposomes. Thus, 
as was shown for other lipid phosphatases and kinases, INPP4A 
phosphatase activity exhibits curvature sensitivity (Fig. 4 D).
Cdc42 guanine nucleotide exchange factor 
activity in extracts is not regulated by 
membrane curvature
Various Cdc42 guanine nucleotide exchange factors contain 
BAR domains and are predicted to localize to regions of high 
membrane curvature. To test whether the activation of Cdc42 
is dependent on either membrane composition or curvature, 
we assayed for the presence of Cdc42⋅GTP (i.e., Cdc42 activa-
tion) on vesicles by sedimentation assays using the G protein– 
binding domain (GBD) from N-WASP (which binds Cdc42⋅GTP 
and not Cdc42⋅GDP) in the context of HSS. These experiments 
demonstrated that GBD recruitment occurs preferentially on 
PI(4,5)P2-containing membranes as compared with PI(3)P- 
containing liposomes, but without any curvature sensitivity 
(Fig. 4 E and Fig. S3 E). The addition of PI(3)P to PI(4,5)P2- 
containing liposomes had no further effect on Cdc42 activation. 
These data show that neither curvature nor synergy with PI(3)P 
triggers Cdc42 activation in the actin polymerization pathway; 
rather, Cdc42 is triggered by PI(4,5)P2 alone.
Mechanism of membrane curvature–
activated actin polymerization
To assess the effects of the combined curvature dependence 
of SNX9 and INPP4A on actin polymerization on the surface 
of PI(4,5)P2/PI(3)P liposomes, we adapted our competitive 
microscopy assay by using 100-nm and 250-nm distributed 
vesicles containing rhodamine-PE or NBD-PE, respectively, 
so that they could be distinguished in the images. Note that 
the vesicles are diffraction limited and will have different flu-
orescent intensities depending on their position in the plane 
of focus as well as their size (Fig. 5, A–D). To obtain a base-
line measure, we first incubated PI(4,5)P2/PI(3)P liposomes 
of both sizes with HSS (Fig.  5, A and E). The addition of 
SNX9 increased the number of 100-nm liposomes that had 
a comet tail (Fig.  5, B and E) without affecting 250-nm li-
posomes. This shows that the curvature selective binding of 
PI(3)P is transduced down the cascade of the actin regulatory 
network to actin polymerization itself. To assess the effect of 
the curvature selectivity of INPP4A, we performed the same 
assay with PI(4,5)P2/PI(3,4)P2 liposomes, preincubating them 
with INPP4A before adding extracts. Compared with PI(4,5)
P2/PI(3)P liposomes, there was an increase in the number of 
comet tails from 100-nm liposomes, showing that PI(3)P pro-
duction is limiting and again that the curvature sensitivity in 
PI(3)P formation is transduced down the cascade of the actin 
regulatory network (Fig. 5, C and E). Combining the effects 
of INPP4A activity with added SNX9 resulted in a further in-
crease in actin polymerization on 100-nm PI(4,5)P2/PI(3,4)P2 
liposomes, again without affecting polymerization on 250-nm 
liposomes (Fig. 5, D and E). Altogether, these results provide 
evidence that at least two molecular mechanisms, SNX9 bind-
ing and INPP4A activation, synergize to trigger actin polym-
erization at sites of high membrane curvature.
INPP4A is important for SNX9 
recruitment to CCPs, revealing CME as 
a functional site of PI(4,5)P2/PI(3)P actin 
polymerization
As yet, no cellular role has been proposed for the coincidence 
detection of two phosphoinositide lipids and membrane cur-
vature. The important combination of signals we identified for 
actin polymerization in frog egg extracts is evocative of endo-
cytosis for several reasons. First, PI(4,5)P2 is enriched at the 
plasma membrane, PI(3)P is produced at the early endosome, 
and membrane curvature increases during CCP maturation. 
Second, SNX9 is mainly recruited at the end of CCP matura-
tion (Taylor et al., 2011; Posor et al., 2013; Schöneberg et al., 
2017) and can induce actin polymerization, which has been im-
plicated in the scission of endocytic vesicles (Lundmark and 
Carlsson, 2009). Finally, knockdown of the PI(3,4)P2 phospha-
tase INPP4A, which produces PI(3)P from PI(3,4)P2, has been 
seen to reduce transferrin uptake (Shin et al., 2005). Moreover, 
although PI(3)P is more conventionally associated with early 
endosomes, PI(3)P is observed at the plasma membrane (Ivetac 
et al., 2005; Shin et al., 2005). Thus, we hypothesized that 
(E) Sedimentation assay of extracts with liposomes that contain 4% PI(4,5)P2; 1% PI(3)P; or 4% PI(4,5)P2/1% PI(3)P and 65% PC; and 30, 34, or 31% PS 
with SNX9, 18, and 33 detected by Western blotting. Quantification from three independent liposome batches and Western blots. Error bars are the SEM. 
One-way ANO VA for SNX9 gives P = 3.113 × 10−8 with Tukey's post-hoc HSD test between PI(4,5)P2 and PI(4,5)P2/PI(3)P: **, P = 0.00100. One-way 
ANO VA for SNX18 gives P = 0.0013 with Tukey's post-hoc HSD test between PI(4,5)P2 and PI(4,5)P2/PI(3)P: *, P = 0.0112. One-way ANO VA for SNX33 
gives P = 10−6 with Tukey's post-hoc HSD test between PI(4,5)P2 and PI(4,5)P2/PI(3)P: **, P = 0.00101.
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PI(3,4)P2 is hydrolyzed to PI(3)P at very late stages of CCP 
maturation and that PI(3)P mediates SNX9 recruitment.
To test whether hydrolysis of PI(3,4)P2 by INPP4A is im-
portant for recruitment of SNX9 and CME, HeLa cells stably 
expressing GFP-SNX9 at approximately twofold endogenous 
levels (Fig. S4, A and B), together with clathrin light chain–
mCherry, were imaged using time-lapse total internal reflection 
fluorescence (TIRF) microscopy (TIR FM). In control condi-
tions, these cells recapitulate the previously reported kinetics 
of SNX9 recruitment (Taylor et al., 2011; Posor et al., 2013), in 
which SNX9 colocalizes with some CCPs shortly before their 
disappearance (Fig. 6 A). In contrast, when levels of INPP4A 
are reduced using any of three separate siRNA sequences, there 
is a drastic drop in the number of SNX9 spots arising in the 
time-lapse experiments (Fig. 6 B, Fig. S4 C, and Videos 1 and 
2). Quantifying the number of spots that appears per unit area 
showed a significant decrease (Fig. 6 C). To confirm the spec-
ificity of the RNAi treatment, we expressed siRNA-resistant 
murine INPP4A isoform 1 in INPP4A siRNA1–treated cells 
and rescued the numbers of SNX9 spots (Fig.  6  C and Fig. 
S4 D). Expression of INPP4A isoform 2, which is missing 
the N-terminal C2 domain, failed to rescue SNX9 assembly 
(Fig. 6 C). At the few CCPs that recruit SNX9 under INPP4A 
knockdown conditions, the SNX9 foci persisted for the same 
time as in WT cells, showing that INPP4A regulates recruitment 
rather than SNX9 lifetime at CCPs (Fig. S4 E). Western blotting 
confirmed INPP4A depletion for each siRNA sequence and that 
endogenous and GFP-tagged SNX9 levels remained the same 
under all conditions (Fig. 6 D).
The extent to which CME depends on actin is variable 
between cell types and conditions and remains poorly under-
stood. We measured the rate of transferrin uptake and found 
that INPP4A knockdown resulted in a modest but significant 
decrease (Fig. 6 E). Interestingly, treatment of these cells with 
latrunculin A inhibited transferrin to a similar extent, whereas 
combining INPP4A knockdown and latrunculin A treatment 
appeared to compound the effect (Fig.  6  E). As these inter-
ventions are not complete, these data could suggest either that 
the two perturbations can both contribute to a single process 
or that there are INPP4A-independent ways in which actin is 
contributing to endocytosis. To measure the effects of INPP4A 
knockdown on the rate of CCP maturation, we quantified the 
Figure 4. Membrane curvature-dependent SNX9 binding and INPP4A activity combine to regulate actin polymerization. (A and B) PI(4,5)P2/PI(3)P lipo-
somes (rhodamine-PE labeled) were incubated with Alexa Fluor 647–SNAP-SNX9 from 15 to 250 nM. Concentrations and the fraction of liposomes with 
SNX9 foci were counted by two-color confocal imaging. Example confocal micrographs of SNX9 (green) bound to 100-nm liposomes (purple, A) and 
250-nm liposomes (purple, B). Bars, 3 µm. (C) The number of SNX9 foci per surface area of membrane calculated using the means determined in Fig. S3 
C. Data are from three independent experiments. (D) Kinetics of PI(3,4)P2 hydrolysis from 100- or 250-nm vesicles by INPP4A. Initial linear rates over the 
first 10 min were 0.0028 ± 0.00008 (100-nm vesicles) and 0.0013 ± 0.00021 (250-nm vesicles); P = 0.0037, n = 3 using Student’s t test. Data are from 
three independent experiments showing the mean and SEM. (E) Cdc42 is not regulated by membrane curvature or PI(3)P. Sedimentation assay of mKate-
GBD for Cdc42⋅GTP activation on 100-nm or 250-nm vesicles (various phosphoinositide compositions, control with PC and 30% PS only) shows that Cdc42 
activation is curvature independent. Quantification from three independent vesicle batches and Western blots. All error bars show SEM.
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dynamic, diffraction-limited CCPs using previously described 
software (Aguet et al., 2013). As expected for HeLa cells as 
well as the larger clathrin plaques, numerous clathrin spots 
within the cells remain for a duration longer than the length 
of the video. The numbers of these persistent CCPs were unaf-
fected by INPP4A siRNA (Fig. 6 F). However, the mean life-
time of the bona fide CCPs was increased (Fig.  6  G) from a 
mean of 24.3 s in control to 56.4 s for INPP4A siRNA1, 35.9 s 
for siRNA2, and 47.9 s for siRNA3. These lifetime data are con-
sistent with the inhibition of CME we detected by transferrin 
uptake. Thus, inhibiting the conversion of PI(3,4)P2 to PI(3)P 
inhibits the recruitment of BAR domain protein SNX9 to CCPs 
and decreases the efficiency of CME.
PI(3)P production and the INPP4A–SNX9 
pathway are needed for actin comets in 
OCRL deficiency
The activity and recruitment of PI 5-phosphatase OCRL to very 
early endosomes to degrade PI(4,5)P2 is highly regulated by 
membrane curvature, protein–protein interactions, and Rab35 
(Billcliff et al., 2016; Cauvin et al., 2016). SNX9 is also reported 
to directly interact with the OCRL (Nández et al., 2014), sug-
gesting a role in rocketing early endosomal intermediates into 
the cell. At the cellular level, mutations in OCRL, which cause 
Lowe syndrome and the less severe Dent-2 disease, disrupt 
actin organization and lead to the formation of SNX9-mediated 
comet tails propelling clathrin-coated vesicles through the cy-
tosol in patient fibroblasts (Nández et al., 2014). We therefore 
surmised that the defects in OCRL may be caused by dysregu-
lation of the SNX9 actin assembly pathway defined herein and 
therefore could be disrupted by inhibiting PI(3)P production.
As an almost complete depletion of OCRL expression is 
required to manifest endocytic defects (Vicinanza et al., 2011) 
and as PI(4,5)P2 enrichment alone might also be expected to 
cause actin comets (by recruiting SNX9 and Cdc42), we sought 
a complete deficiency while also controlling the genetic back-
ground of cells to create control and OCRL-deficient cells that 
were perfectly matched. We made retinal pigmented epithelial 
(RPE-1) cells deficient in OCRL and similar to mutations that 
occur in Lowe syndrome by targeting exon 9 using CRI SPR-
Cas9D10A nickase–based genome editing (Fig. S5, A–D). The 
OCRL-deficient cells recapitulated the actin comet phenotype 
previously characterized in patient fibroblasts as observed 
by expression of the fluorescent actin probe F-tractin using 
live-cell spinning-disk confocal microscopy (Fig.  7, A and 
B; and Video  3). Expression levels of SNX9 are unchanged 
in OCRL-deficient cells compared with control RPE-1 cells 
(Fig. 7 C). However, immunolabeling for the endogenous pro-
tein revealed the accumulation of distinct SNX9 foci at the heads 
of the actin comets in OCRL knockout (KO) cells (Fig. 7, D and 
Figure 5. Membrane curvature preferences in INPP4A and SNX9 propagate to actin polymerization. Direct observation of vesicle samples containing 
100-nm (rhodamine fluorescence, purple) and 250-nm (NBD, cyan) vesicles in a 1:1 ratio. (A) The lipid composition was 4% PI(4,5)P2, 1% PI(3)P, 65% 
PC, and 30% PS, and actin polymerization was triggered by the addition of HSS. (B) The lipid composition was 4% PI(4,5)P2, 1% PI(3)P, 65% PC, and 
30% PS, and actin polymerization was triggered by the addition of HSS supplemented with 100 nM SNX9. (C) The lipid composition was 4% PI(4,5)P2, 
10% PI(3,4)P2, 65% PC, and 30% PS preincubated with INPP4A. Polymerization was triggered by addition of HSS plus actin. (D) The lipid composition 
was 4% PI(4,5)P2, 10% PI(3,4)P2, 65% PC, and 30% PS preincubated with INPP4A. Polymerization was triggered by addition of HSS plus 100 nM SNX9 
and actin. (E) Quantification of three independent experiments, 10 fields of view per condition (∼700 vesicles). One-way ANO VA between all conditions 
tested is significant: P = 0.0002. By post-hoc Tukey's HSD test, difference between extracts only and extracts plus SNX9: *, P = 0.040; for extracts only 
and extracts plus INPP4A: **, P = 0.005; and for extracts only and extracts plus INPP4A + SNX9: **, P = 0.001.
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E; and Fig. S5 E), as previously observed in patient fibroblasts 
(Nández et al., 2014). Expression of a murine mCherry-OCRL 
rescue construct abolished the appearance of these comets (Fig. 
S5, F and G; and Video 4).
To reduce PI(3)P availability on the aberrant rocketing 
vesicles, we first targeted INPP4A, the endocytic source of 
PI(3)P we identified earlier. Treatment of OCRL KO cells with 
INPP4A siRNA resulted in a significant, ∼50% decrease in the 
number of actin comets (Fig. 7, F–H; and Video 5). There was 
no difference in the mean duration, distance, or speed of the 
comets tracked. To more broadly inhibit PI(3)P production, 
we treated OCRL-deficient cells with either a broad range or a 
more specific class III PI 3-kinase inhibitor. We used the irre-
versible covalent inhibitor wortmannin, which targeted PI(3)P 
production by class I (for example, via SHIP2 dephosphoryla-
tion of PI(3,4,5)P3), class III (that phosphorylate phosphatidy-
linositol on early endosomes), and class II PI 3-kinases (that 
are used during endocytosis to make PI(3,4)P2). To specifically 
inhibit class III PI 3-kinases, which are of particular interest 
because of the late CCP/early endosome character of the rocket-
ing intermediates, we used Vps34-IN1 (Bago et al., 2014). Both 
wortmannin and Vps34-IN1 treatments caused a significant 
Figure 6. PI(4,5)P2/PI(3)P stimulated actin 
polymerization functions during CME. (A) TIR 
FM imaging (4 min) of a cell stably express-
ing GFP-SNX9 and transiently transfected with 
clathrin-Lca-mCherry. A region of interest indi-
cated by the white dashed line is presented as 
a kymograph. SNX9 frequently peaks at the 
end of the clathrin track, indicated by white 
arrowheads. Bar, 1 µm. (B) HeLa cells stably 
expressing GFP-SNX9 are presented from 
single frames of TIR FM videos. Recordings 
of the accumulated GFP-SNX9 spots during 
a 4-min TIF RM time lapse are overlaid in the 
representative micrographs on the right. Bars, 
10 µm. siRNA-mediated INPP4A knockdown 
decreases the number of SNX9 spots forming 
at the cell surface. (C) Quantification of SNX9 
spot dynamics from three to eight cells per 
sample from three independent experiments. 
Student's t test between control and siRNA1: 
**, P = 0.0043. Between siRNA1 and siRNA1 
+ muINPP4A1-mCherry: **, P = 0.004. 
(D) Western blots (WB) showing that levels 
of GFP-SNX9 and endogenous SNX9 remain 
the same in INPP4A knockdown cells. Levels 
of INPP4A are reduced with all three siRNAs 
against INPP4A. INPP4A was concentrated by 
immunoprecipitation (IP) and then detected by 
Western blotting. Expression of murine INPP4A 
and variant1-mCherry is resistant to INPP4A 
siRNA1 and 3. (E) Transferrin uptake was re-
duced on INPP4A reduction and latrunculin A 
treatment. Transferrin internalization was mea-
sured without fetal bovine serum starvation 
(steady state) to avoid perturbation of CME. 
Quantification was from three independent ex-
periments; ordinary one-way ANO VA gives P 
= 0.0033; Tukey's HSD test control to INPP4A 
siRNA: *, P = 0.0431; control to INPP4A 
siRNA + Lat: **, P = 0.0021; and control + Lat 
compared with INPP4A + Lat: *, P = 0.0408. 
(F) Persistent CCPs (of long duration and large 
size) are unaffected by INPP4A siRNA. n = 
15 control, 13 INPP4A siRNA1-, 8 siRNA2-, 
and 5 siRNA3-treated cells. ns, not significant. 
(G) Lifetime of remaining CCPs was increased 
with INPP4A knockdown. Numbers of CCPs 
analyzed were control, 4,122; INPP4A 
siRNA1, 1,340; INPP4A siRNA2, 1,573; and 
INPP4A siRNA3, 629. Kolmogorov–Smirnov 
test control versus INPP4A siRNA1 is P < 
0.0001, control versus INPP4A siRNA2 is P = 
0.0268, and control versus INPP4A siRNA3 is 
P < 0.0001. Error bars show SEM.
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Figure 7. Actin comets in OCRL-deficient RPE cells and their reduction on INPP4A siRNA. (A) Live imaging over a 4-min period of F-tractin expressing con-
trol RPE and OCRL KO cells as shown in Video 3, showing motile actin comets in the KO not observed in control cells. The single channel image indicates 
a single time point, and the colored image shows a projection of the entire time course, temporally colored as indicated. (B) Quantification of actin comets 
from n = 24 cell regions for each condition. Each data point is plotted individually, along with the mean ± SEM for each condition. Difference assessed by 
Student’s t test. ***, P < 0.0001. (C) Western blot confirming OCRL KO in the OCRL KO CRI SPR/Cas9 edited clone. Levels of SNX9 remain unchanged. 
α-Tubulin acts as a loading control. (D and E) Control and OCRL KO cells expressing GFP–F-tractin and immunolabeled for SNX9 with enlarged regions 
as insets. SNX9 puncta are always located at the head of actin comets (arrowheads in E). (F) Live imaging over a 4-min period of F-tractin OCRL KO cells 
treated with nontargeting control siRNA or INPP4A siRNA1, as shown in Video 5, showing reduction in comets on INPP4A knockdown. Bars: (main im-
ages) 10 µm; (insets) 5 µm. (G) Quantification of actin comets from n = 30 cell regions for each treatment. Bars indicate the mean ± SEM for each condition. 
Difference assessed by Student’s t test. **, P = 0.002. (H) Western blot verifies INPP4A knockdown in the OCRL KO clone. 
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reduction in PI(3)P puncta in OCRL-deficient cells compared 
with controls, revealed by staining in fixed cells using the pu-
rified mCherry-2×FYVE domain (Fig.  8  A). Examination of 
actin comet tail formation in OCRL-deficient cells treated with 
the inhibitors revealed a >50% reduction in the number of actin 
comets for both wortmannin and Vps34-IN1 (Fig. 8, B and C; 
and Video 6). Though there was no change in the mean velocity 
of the tracked comets, there was a small but significant decrease 
in both mean track duration (14.48 ± 0.186 s control vs. 13.15 ± 
0.04 s wortmannin [P = 0.0042] or 13.04 ± 0.2997 s Vps34-IN1 
[P = 0.0027], overall ANO VA P = 0.0022) and distance trav-
eled (2.26 ± 0.0461 µm control vs. 2.07 ± 0.04 µm wortmannin 
[P = 0.0404] or 1.995 ± 0.0594 µm Vps34-IN1 [P = 0.0099], 
overall ANO VA P = 0.0125). (Values are the means ± SEM, 
and statistics were assessed by ordinary one-way ANO VA with 
Dunnett’s multiple comparisons test). Thus, these data suggest 
that (a) PI(3)P is needed for actin comet tail formation, (b) the 
PI(3)P arises from INPP4A and class III PI 3-kinase routes of 
phosphoinositide conversion, and (c) PI 3-kinase inhibitors may 
provide a therapeutic option for disease symptoms.
Discussion
We have discovered and fully reconstituted a SNX9-depen-
dent signaling pathway that links its unique ability to coinci-
dently detect PI(4,5)P2, PI(3)P, and membrane curvature with 
recruitment and activation of Cdc42, N-WASP, and Arp2/3 
complex to trigger actin polymerization (Fig. 8 D). Given the 
well-established conversion of phosphatidylinositol that occurs 
during CME progression and the kinetic data on SNX9 (Tay-
lor et al., 2011; Schöneberg et al., 2017), we propose that this 
pathway functions at late stages of CME, in concert with the 
curvature-dependent activity of the PI 4-phosphatase INPP4A 
to activate actin assembly at stalled CCP intermediates. SNX9 
has recently been localized to highly curved regions of late 
CCPs by high precision using correlative single-molecule lo-
calization and EM, suggesting the coincidence of PI(4,5)P2 
and PI(3)P at late budding profiles (Schöneberg et al., 2017; 
Sochacki et al., 2017).
Previous studies have suggested that PI(3,4)P2 functions 
to recruit SNX9 to late-stage CCPs (Posor et al., 2013; Schöne-
berg et al., 2017). However, our findings instead suggest that 
PI(3,4)P2 serves as a substrate for the INPP4A phosphatase to 
generate PI(3)P that functions synergistically with PI(4,5)P2 on 
the plasma membrane to recruit SNX9 and activate actin po-
lymerization. Consistent with this, we show that INPP4A is 
necessary for SNX9 recruitment to CCPs.
We reconstituted SNX9-dependent actin polymerization 
from purified components to show that Cdc42 and N-WASP are 
both necessary and sufficient to activate the Arp2/3 complex in 
response to PI(4,5)P2/PI(3)P signals. Cdc42 activation responds 
to PI(4,5)P2 but not PI(3)P or membrane curvature. SNX9-me-
diated actin polymerization has previously been reconstituted 
on PI(4,5)P2 vesicles in a purified system similar to this one, 
but without Cdc42 (Yarar et al., 2007). We speculate that the 
difference in these results comes from our use of the N-WASP–
WIP complex, which is more strongly autoinhibited than free 
N-WASP, as used previously (Yarar et al., 2007).
The SNX9 PX–BAR domain is uniquely structured to in-
tegrate all three combinatorial membrane signals. SNX9 binds 
to PI(4,5)P2-containing vesicles primarily via clusters of posi-
tive charges on the BAR domain and with lower affinity to PI(3)
P-binding sites via the PX domain. Both sites are necessary for 
the high-affinity binding to PI(4,5)P2/PI(3)P-containing vesi-
cles. In addition to specific lipid binding, we determined that 
SNX9 binds membranes of clathrin-coated vesicle–sized radius 
∼10-fold better than those of lower curvature. Interestingly, 
the ability to bind two phosphoinositide lipids synergistically 
appears to be conserved and unique among the closely related 
SNX9/18/33 subfamily but not shared by other more distantly 
related PX–BAR domain–containing sorting nexins. The curva-
ture dependence of INPP4A activity in generating PI(3)P works 
in concert with SNX9 to drive actin polymerization of curved 
PI(4,5)P2- and PI(3)P-containing membranes.
During maturation and the inward budding of CCPs, their 
increasing curvature activates phosphatidylinositol modifica-
tions via activation of synaptojanin (Chang-Ileto et al., 2011), 
class II PI 3-kinase (Hübner et al., 1998), and OCRL (Billcliff et 
al., 2016). We now show that this is also the case for a subsequent 
step, INPP4A hydrolysis of PI(3,4)P2 to PI(3)P. The production 
of PI(3)P acts as a second messenger for curvature through the 
multistep enzyme catalysis. As binding to PI(3)P by SNX9 is 
also curvature dependent, these combinatorial inputs trigger a 
signaling cascade toward actin polymerization (Fig. 8 D). To our 
knowledge, this work is the first demonstration of membrane 
curvature controlling a complex process (Arp2/3-mediated 
actin polymerization) downstream of an initial curvature- 
dependent event (INPP4A catalysis and SNX9 binding).
In CME, this signaling cascade could act as a timer: if ves-
icle scission occurs rapidly, PI(4,5)P2, PI(3)P, and curvature will 
not coincide and thus, CME will be actin independent. However, 
if scission is delayed (for example when membrane tension is 
high), the lifetime of this normally transient triple intermediate 
would be prolonged, allowing for SNX9 recruitment and the re-
sulting actin polymerization to exert force on the membrane. The 
role of actin in CME has been debated but appears to be required 
at only a subset of CCPs (Taylor et al., 2011) or when membrane 
tension is high (Boulant et al., 2011). Consistent with this model, 
we observed a significant but modest inhibition of CME in HeLa 
cells treated with INPP4A that was no greater than the effect of 
disrupting actin assembly with latrunculin A. SNX9 knockdown 
has been similarly shown to have a modest effect on CME in 
most cells (Soulet et al., 2005; Bendris et al., 2016).
In agreement with our model, actin and SNX9 are co-
opted when scission fails in dynamin KO cells (Ferguson et al., 
2009). Likewise, in COS-7 cells, LifeAct fluorescence was ob-
served during the final five frames of the clathrin signal at about 
half the budding CCPs, consistent with a model in which the 
triple PI(4,5)P2/PI(3)P/curved intermediate is only sometimes 
formed (Li et al., 2015). In yeast, where actin is used constitu-
tively, there is no SNX9, and the molecular mechanism of actin 
involvement is different to the one we find here (Lewellyn et 
al., 2015). Though we have provided initial data that the path-
way we identified biochemically is relevant to studies of CME, 
much further work is needed to fully understand how the path-
way we have identified functions during CME. In view of our 
model, it will be particularly interesting to determine whether 
INPP4A and SNX9 are more strongly required in cells where 
actin is always used during CME (Grassart et al., 2014) or in 
high membrane tension conditions, such as in clathrin plaques 
where actin is used for scission (Boulant et al., 2011).
Previous observations had revealed that OCRL-deficient 
cells have aberrant actin organization and that reducing the 
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Figure 8. PI 3-kinase inhibitors decrease the number of actin comet tails in OCRL-deficient cells and overall model. (A) Purified mCherry-2×FYVE domain 
used to stain for PI(3)P in cells fixed after treatment with DMSO control, 2 µM wortmannin, or 10 µM Vps34-IN1 in serum-free media for 1 h before imag-
ing. (B) Representative images from time-lapse videos of OCRL-deficient cells expressing F-tractin and treatment with DMSO or the inhibitors, as shown in 
Video 6. Actin comets were reduced on PI 3-kinase inhibitor treatment. Bars, 10 µm. (C) Quantification of actin comets from n = 30 cell regions for each 
treatment. Bars indicate the mean ± SEM for each condition. Difference assessed by ordinary one-way ANO VA with Dunnett’s multiple comparisons test, 
overall ANO VA, and comparing each inhibitor treatment to DMSO control cells. ***, P ≤ 0.0001. (D) Pathway of curvature signaling to actin polym-
erization via PI(4,5)P2/PI(3)P/SNX9 during CME. High curvature activates a cascade of phosphoinositol metabolism to change membrane identity and 
trigger actin polymerization at PI(4,5)P2/PI(3)P-enriched and highly curved sites via the oligomerization of SNX9 during endocytosis. In Lowe syndrome, 
OCRL deficiency increases PI(4,5)P2 levels on PI(3)P intermediates, triggering SNX9 assembly. PI(4,5)P2 also activates Cdc42 (independently of the 
curvature) for the relief of N-WASP inhibition. N-WASP oligomerization (via SNX9 binding) finally drives superactivation of the Arp2/3 complex and, 
thus, actin polymerization.
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levels of either N-WASP, SNX9, or PI 5-kinase, adding latrun-
culin B, or overexpression of the actin-severing protein cofilin 
all rescued actin organization and endosomal trafficking defects 
(Vicinanza et al., 2011; Nández et al., 2014). Here, we have 
shown that the normally transient coincidence of PI(4,5)P2 and 
PI(3)P is sustained in OCRL mutant cells and that the formation 
of actin comets on endocytic vesicles in OCRL mutant cells in-
volves the SNX9 and INPP4A signaling cascade we have identi-
fied. By editing the genome of RPE-1 cells to mimic the OCRL 
deficiency in Lowe syndrome, we revealed that PI(3)P has a 
role in stimulating actin polymerization at the aberrant, still 
clathrin-coated (Nández et al., 2014) endocytic intermediates 
that rocket around these cells. siRNA knockdown and inhibitor 
studies established that not only is there a role for PI(3)P pro-
duction via INPP4A, but also through PI 3-kinases, particularly 
class III PI 3-kinase. The effect of inhibiting PI(3)P production 
is substantial but not complete. This likely reflects the fact that 
actin polymerization can still be triggered by high PI(4,5)P2 ob-
served in OCRL-deficient cells (Vicinanza et al., 2011), which 
can still recruit SNX9 and activated Cdc42. Nonetheless, these 
findings suggest the use of PI 3-kinase inhibitors initially devel-
oped for cancer indications as therapeutic approaches for Lowe 
syndrome (Rodon et al., 2013; Pasquier et al., 2015).
We demonstrate here how a trio of coincident effectors, 
PI(4,5)P2, PI(3)P, and membrane curvature, operates transiently 
to amplify and transduce signals from the membrane to locally 
activate the actin machinery. Our work provides a novel mech-
anism by which actin polymerization can be specifically trig-
gered when and where it is needed in the cell. We show here 
that adapter proteins and the membrane environment can be 
critical factors driving actin polymerization at specific cellular 
locations. Arp2/3 complex–mediated actin nucleation is consti-
tutively autoinhibited, and we demonstrate how a timed triple 
confluence of membrane signals unlocks an actin burst to power 
vesicle rocketing in health and disease.
Materials and methods
This research has been regulated under the Animals (Scientific Proce-
dures) Act 1986 Amendment Regulations 2012 after ethical review by 
the University of Cambridge Animal Welfare and Ethical Review Body.
Plasmids
The all-in-one Cas9D10A nickase vector was a gift from S. Jackson (Gur-
don Institute, University of Cambridge, Cambridge, England, UK). 
Murine INPP4A variant 1 (muINPP4A1) cDNA ORF clone (Gen-
Bank accession no. NM_030266) was obtained from Origene, PCR 
amplified with Xho1 and SacII flanking restriction sites, and cloned 
into pmCherry-N1 to generate muINPP4A1-mCherry. Clathrin-Lca-
mCherry was cloned from clathrin-Lca-EGFP (a gift from T. Kirch-
hausen, Harvard Medical School, Boston, MA). NeonGreen- and tomato 
F-tractin constructs were gifts from J.A. Hammer III (National Heart, 
Lung, and Blood Institute, National Institutes of Health, Bethesda, MD). 
Murine OCRL1-pmCherryC1 was a gift from C. Merrifield (Univer-
site Paris-Saclay, Paris, France; plasmid 27675; Addgene; Taylor et al., 
2011). X. laevis SNX9 was PCR amplified from pCMV-sport6-SNX9 
(IMA GE clone 3402622; Source Bioscience) with FseI–AscI flanking 
restriction sites and cloned into pCS2-his-SNAP-FA to generate His-
SNAP-SNX9. Similarly, X. tropicalis N-WASP (WASL) was PCR am-
plified from IMA GE clone 5379332 (Source Bioscience) and cloned 
into pCS2-his-SNAP-FA. Human N-WASP wGBD domain was PCR 
amplified from pCS2-mRFP-wGBD (a gift from W. Bement, University 
of Wisconsin-Madison, Madison, WI; plasmid 26733; Addgene) with 
XhoI–AscI flanking restriction sites and cloned into pET-pmKate2 to 
generate mKate-GBD. pCS2-His-Cdc42 (Q61L), pCS2-ZZ-TEV-WIP, 
pCS2-GFP-his-Cdc42, pGEX-NWA SP-CA domain, and pGEX-NWA 
SP-VCA domain plasmids were gifts from M. Kirschner (Harvard Med-
ical School). Human Cdc42 was PCR amplified with FseI–AscI flanking 
restriction sites and cloned into pCS2-his-GST-FA to generate GST-
Cdc42. X. laevis SNX9 mutants were designed based on sequence align-
ments with human SNX9 and mutants previously described for human 
SNX9 (Pylypenko et al., 2007). Site-directed mutagenesis of pCS2-his-
SNAP-SNX9 was performed using the following primer pairs: Y276A/
K302A (Y276A, 5′-GTA AAC CAC AGG GCT AAG CAC TTTG-3′ and 
5′-CAA AGT GCT TAG CCC TGT GGT TTAC-3′; K302A, 5′-CTC TTC 
CAG ACG CGC AAG TTA CAGG-3′ and 5′-CCT GTA ACT TGC GCG 
TCT GGA AGAG-3′) and K511E/K517E (K511E, 5′-GTA AAG GAA 
AGT GAT GAA TTG GTG GTT GCAG-3′ and 5′-CTG CAA CCA CCA 
ATT CAT CAC TTT CCT TTAC-3′; K517E, 5′-GGT TGC AGG TGA AAT 
TAC ACA GC-3′ and 5′-GCT GTG TAA TTT CAC CTG CAA CC-3′).
Cell culture
Cell lines were incubated at 37°C in 5% CO2 and were passaged two 
to three times weekly. RPE-1 cells (a gift from S.  Jackson, Gurdon 
Institute, University of Cambridge) were maintained in DMEM/F12 
media supplemented with 10% fetal bovine serum, 0.25% sodium bi-
carbonate (Sigma-Aldrich), 100 µg/ml penicillin/100 U/ml streptomy-
cin, and 2 mM l-glutamine (Gibco). Flp-In TRex HeLa cells (gift from 
S.S. Taylor, University of Manchester, Manchester, England, UK) were 
maintained in DMEM media (Gibco) supplemented with 10% fetal bo-
vine serum, 100 µg/ml hygromycin B, and 5 µg/ml blasticidin S HCl 
(Invitrogen). To generate a stable inducible cell line, SNX9 was PCR 
amplified and cloned into a pcDNA5/FRT/TO vector modified to con-
tain an N-terminal GFP tag. The construct was then cotransfected into 
cells with the Flp recombinase–encoding plasmid pOG44 as described 
by the vendor (Invitrogen). Recombinant GFP-SNX9 expression was 
induced by incubation with 1 ng/ml doxycycline hyclate (Sigma- 
Aldrich) for 24 h. For protein expression, Freestyle 293F cells (Thermo 
Fisher Scientific) were maintained in Freestyle 293 expression medium 
according to the manufacturer’s instructions.
siRNA and plasmid transfection
siRNA sequences were transfected into Flp-In TRex HeLa cells using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s in-
structions 72 h before analysis. The following siRNAs were used (all 
Stealth siRNA from Invitrogen): negative control (GC duplex medium), 
AP2M1 siRNA (AP2M1HSS101955), and INPP4A siRNAs (siRNA1, 
HSS105457; siRNA2, HSS105458; siRNA3, HSS105459). Constructs 
were transfected into Flp-In TRex HeLa cells using Lipofectamine 2000 
24 h before analysis. In RPE-1 cells, Jetprime (Polyplus) was used to 
transfect in plasmid constructs 24 h before analysis, using a maximum 
of 2 µg DNA per 3-cm imaging dish. For siRNA treatment, cells were 
treated with two shots of siRNA at 48 and 24  h before analysis. The 
first transfection was performed using Lipofectamine RNAiMAX (Invit-
rogen) according to the manufacturer’s instructions, whereas the second 
was delivered 24 h before analysis concurrent with the DNA transfec-
tion using Jetprime, as outlined above. The following siRNAs were used: 
INPP4A siRNA1 (HSS105457; Invitrogen, as above) and siGEN OME 
control nontargeting siRNA2 (D-001210-02-05; Dharmacon).
CRI SPR KO of OCRL in RPE-1 cells
The all-in-one Cas9D10A nickase vector used was described previously 
(Chiang et al., 2016). Exon 9 of human OCRL was targeted using a 
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single-guide RNA (sgRNA) pair designed using the Zhang laboratory 
CRI SPR Design Nickase Analysis tool (Hsu et al., 2013). sgRNAs (se-
quences shown in Fig. S5) were synthesized with 5′-P-accg or 5′-P-aaac 
overhangs on the forward and reverse oligonucleotides, respectively, 
for restriction ligation (P, phosphate; Sigma-Aldrich). The annealed an-
tisense and sense sgRNAs were sequentially cloned into the BsaI and 
BbsI restriction sites of the vector, respectively. RPE-1 cells were trans-
fected with the plasmid (as above), and, after 24 h, transfected single 
cells transiently expressing RFP were individually deposited into 96-
well plate wells by FACS to generate monoclonal cultures (Flow Cy-
tometry Facility, Wellcome Trust–Medical Research Council Stem Cell 
Institute, University of Cambridge). Once individual clones had grown 
up, they were screened for OCRL expression by Western blot, with the 
sequence of positive clones lacking OCRL verified by PCR amplifica-
tion of the genomic region around the exon 9 target site and with the 
bands representing each mutant allele extracted and sent for sequencing 
(Source Bioscience). The following primers were used for PCR ampli-
fication and sequencing of the product: forward, 5′-GCC CAC TGC CTT 
TGT GTT CT-3′; reverse, 5′-TGT CAC TGT TAG AAC TGA CCC CA-3′.
Antibodies and fluorescent protein reagents
The following antibodies were used in this study: rabbit anti-Arp2 
(sc-15389; [H-84]; Santa Cruz), rabbit anti-GST (ab9085; Abcam), 
rabbit anti-tRFP (AB234; Cambridge Bioscience), goat anti-INPP4A 
(sc-12314; [N-15]; Santa Cruz), rabbit anti-INPP4A (ab109622; 
[EP3425(2)]; Abcam), mouse anti-clathrin heavy chain antibody 
(610499; BD Transduction Laboratories), mouse anti-AP50/AP2M1 
(611353; BD Transduction Laboratories), rabbit anti-SNX9 (a gift 
from S. Carlsson, Umeå University, Umeå, Sweden), mouse anti-SNX9 
(ab118996; [2F1]; Abcam), rabbit anti-OCRL (ab181039; [EP10256]; 
Abcam), rabbit anti-RFP (600–401-379; Rockland), and mouse an-
ti–α-tubulin (ab7291; [DM1A]; Abcam). Secondary antibodies were 
conjugated to Alexa Fluor 568 or 647 (Molecular Probes) for immuno-
labeling or to CW680 and 800 fluorescent probes (LI-COR Biosciences) 
for Western blotting. Pyrene actin was purchased from Cytoskeleton. 
Fluorescent actin was purchased from Thermo Fisher Scientific. 6×His-
tagged human INPP4A was obtained from Echelon Biosciences.
Immunoprecipitation, SDS-PAGE, and Western blotting
Cells were grown on plastic plates and were washed with ice-cold PBS. 
Ice-cold lysis buffer (20  mM Hepes, pH 7.4, 100  mM NaCl, 2  mM 
MgCl2, 0.1 mM EDTA, 1% NP-40, protease inhibitor cocktail [set III; 
Calbiochem], and phosphatase inhibitors, pH 7.4) was added to each 
plate and left on ice for 30 min before cells were scraped off, resus-
pended, and spun down at max speed in a tabletop centrifuge. To probe 
for INPP4A in Flp-In TRex HeLa cells, the supernatant was incubated 
with 10 µl of protein G magnetic beads (GE Healthcare) preincubated 
with 1 µg of goat anti-INPP4A overnight at 4°C. The beads were sed-
imented and washed extensively with lysis buffer and boiled in SDS 
sample buffer, and the eluted material was analyzed by Western blot-
ting. For SDS-PAGE analysis, samples were boiled in SDS sample 
buffer, run on 4–20% polyacrylamide gels (BioRad) according to the 
manufacturer’s instructions, and analyzed by either adding InstantBlue 
(Expedeon) or by Western blotting using an iBlot 2 Dry Blotting Sys-
tem for transfer (Life Technologies), IRDye antigen detection, and an 
Odyssey Sa reader (LI-COR Biosciences).
Protein purifications
Unless otherwise indicated, chemicals were purchased from Sigma- 
Aldrich. All steps were performed at 4°C, and purified proteins were 
concentrated using a 10,000 MWCO spin concentrator (Millipore). 
Their concentrations were determined based on their absorption at 280 
nm, and they were stored at −80°C in 10% glycerol after snap freez-
ing in liquid nitrogen. 
Arp2/3 complex
Bovine Arp2/3 complex was purified as previously described, except 
using GST-CA rather than GST-VCA (Ho et al., 2006). Arp2/3 was 
purified from X.  laevis egg extracts using a modified similar proto-
col. Crude cytosolic extract was prepared as described previously 
(Walrant et al., 2015), diluted 1:2 into MES buffer (100  mM MES, 
pH 6.8, 0.2 mM EGTA, 0.5 mM MgCl2, 0.1 mM EDTA, and 1 mM 
DTT), and centrifuged at 50,000 rpm for 1 h in a rotor (70Ti; Beckman 
Coulter). The supernatant was collected and dialyzed into SP buffer 
(50 mM MES, pH 6.8, 1 mM EDTA, 1 mM MgCl2, and 1 mM DTT) in 
a 10,000 MWCO cassette (Thermo Fisher Scientific) and then applied 
to a sulphopropyl fast flow (SP FF) column (Hi Trap; GE Healthcare) 
on an ÄKTA flow pressure liquid chromatography (FPLC) system 
(GE Healthcare). The column was washed with 10 mM KCl-SP buf-
fer and then eluted with 80 mM KCl-SP buffer. Fractions containing 
Arp2/3 complex were pooled and dialyzed overnight into GST-CA 
loading buffer (20  mM Hepes, pH 7.4, 25  mM KCl, 1  mM MgCl2, 
0.5 mM EDTA, 0.1 mM Na-ATP-Tris, and 1 mM DTT). A GST-CA 
column was prepared from BL21 pLysS Escherichia coli expressing 
the GST-CA construct. Bacteria were harvested, resuspended in buffer 
A (containing 150 mM NaCl, 20 mM Hepes, pH 7.4, 2 mM EDTA, and 
2 mM DTT), and lysed by probe sonication. After ultracentrifugation 
(40,000 rpm for 45 min in a 70Ti rotor), the bacterial supernatant was 
incubated with glutathione–Sepharose 4B (GS) beads (GE Healthcare). 
After extensive washing in buffer A/high salt buffer A (300 mM NaCl), 
the dialyzed SP column elution was applied to the GST-CA column. 
After extensive washing in 0.2 M KCl-GST-CA loading buffer, samples 
were eluted in a disposable column by the addition of 0.5-ml aliquots 
of 0.2 M MgCl2-GST-CA loading buffer. Fractions containing Arp2/3 
complex were pooled and underwent gel filtration on a gel filtration 
column (HiLoad 26/600 Superdex 200; GE Healthcare) into Arp2/3 
storage buffer (10  mM Hepes, pH 7.4, 50  mM KCl, 1  mM MgCl2, 
1 mM EGTA, and 1 mM DTT). 
6×His-SNAP-SNX9 and SNX9 mutants, 6×His-mKate-wGBD, 6×His-
mCherry-2×FYVE, 6×His-eGFP-2×PH-TAPP1, and GST-SNAP-2×FYVE
pCS2 constructs were transfected into 293F cells by 293fectin reagent 
(Thermo Fisher Scientific) according to the manufacturer’s instructions 
48 h before harvesting. 293F cell pellets were resuspended in buffer con-
taining EDTA-free cOmplete protease inhibitor tablets (Roche) before 
lysis by probe sonication. pET and pGEX plasmids were transformed 
into BL21 pLysS E. coli and induced overnight at 19°C. Bacteria were 
harvested and lysed by probe sonication in buffers containing 150 mM 
NaCl and 20 mM Hepes, pH 7.4, with 2 mM 2-mercaptoethanol for 
6×His tags and 2 mM EDTA and 2 mM DTT for the GST tag. After 
ultracentrifugation (40,000 rpm for 45 min in a 70Ti rotor), proteins 
were affinity purified on nickel–nitrilotriacetic acid (Ni-NTA) agarose 
beads (Qiagen) for the 6×His tag or GS beads (GE Healthcare) for the 
GST tag. GST proteins were cleaved using tobacco etch virus (TEV) 
protease. 6×His tag proteins were eluted from Ni-NTA beads by step-
wise addition of increasing concentrations of 50–300 mM imidazole 
in a buffer also containing 20 mM Hepes, pH 7.4, 150 mM NaCl, and 
2 mM 2-mercaptoethanol. Fractions containing cleaved or eluted pro-
teins were pooled and purified further using S200 gel filtration on an 
ÄKTA FPLC. SNAP-SNXs in pGEX plasmids were transformed into 
BL21 pLysS E. coli and induced for 3 h at 37°C. Bacteria were har-
vested and lysed by probe sonication in buffers containing 150  mM 
NaCl and 20 mM Hepes, pH 7.4, with 2 mM DTT. After ultracentrif-
ugation (40,000 rpm for 45 min in a 70Ti rotor), proteins were affinity 
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purified on GS beads. GST proteins were cleaved using thrombin pro-
tease. Thrombin was finally inactivated by the addition of 1 mM PMSF. 
Cdc42
For expression of GST-Cdc42, 293F cells were transfected as above, 
subcultured 48 h after transfection at a 1:2 ratio, and given a second 
transfection of the plasmid, with the cells harvested 24  h later. Iso-
prenylated GST-Cdc42 was purified from the membranes of 293F 
pellets and loaded with GTP-γS or GDP as described by Lebensohn 
et al. (2006), with the protein eluted in 50  mM Tris-HCl, pH 8.0, 
10  mM reduced glutathione, 1  mM DTT, and 0.1% wt/vol sodium 
cholate hydrate according to the GS bead manufacturer’s instructions 
(GE Healthcare). Samples containing eluted protein were pooled 
and buffer exchanged by spin concentration into storage buffer. Iso-
prenylated hexahistidine-tagged Q61L Cdc42 was extracted from the 
membranes of 293F pellets as for GST-Cdc42 and purified on Ni-NTA 
agarose beads as above. 
SNAP–N-WASP–ZZ-WIP
SNAP-tagged X.  tropicalis N-WASP in complex with ZZ-tagged 
human WIP was purified from 293F cells based on methods previously 
described (Ho et al., 2004). The ZZ-WIP contains a TEV cleavage site 
between the tag and the protein. Lysates were incubated with IgG Sep-
harose 6 beads (GE Healthcare) in XB buffer (100 mM KCl, 0.1 mM 
CaCl2, 1 mM MgCl2, and 10 mM Hepes, pH 7.4). After extensive wash-
ing, TEV protease was added in XB buffer containing 10 mM DTT 
and 10% glycerol and incubated overnight to cleave the N-WASP–WIP 
complex from the beads. The disposable column was drained to collect 
the cleaved protein complex and applied to a small volume of GS beads 
to sequester the TEV protease. 
Actin preparation procedure
Actin was prepared according to the previously published protocol 
(Pardee and Spudich, 1982). The muscle from the leg of a freshly killed 
rabbit (same day, kept on ice) was taken, removing fat and connective 
tissue. The muscle was minced twice with a meat grinder and extracted 
in Guba Straub buffer (0.3 M NaCl, 0.1 M NaH2PO4 [2H20], 5 mM 
Na2HPO4, 1  mM NaN3, 0.05  mM PMSF, 1  mM MgCl2, and 1  mM 
Na4P2O7, pH to 6.5, adding 1 ml of 200 mM ATP just before use), stir-
ring consistently for 10–15 min. The muscle was centrifuged at 3,000 
rpm in a J6-MC centrifuge (rotor TY.JS 4.2; Beckman Coulter) pre-
cooled to 4°C. The muscle residue was resuspended in 1 liter of buffer 
containing 4% NaHCO3 and 1 mM CaCl2 plus 9 liters distilled H2O 
(dH2O), stirred for 15 min and filtered through four layers of cheese-
cloth. The muscle residue was diluted into 10 liters dH2O and quickly 
squeezed through cheesecloth (working quickly as muscle swells at low 
ionic strength, and F-actin is converted to G-actin and would be lost). 
The residue was suspended in 2.5 liters of cold acetone, stirred at room 
temperature for 15 min, and then filtered through cheesecloth. Ace-
tone washing and filtering was repeated until the supernatant became 
clear (three to four times). The muscle powder was spread out on filter 
paper and dried in the fume hood overnight. Once dry, it was stored at 
−80°C. Stringy parts of the muscle acetone powder were separated, and 
5 g was weighed out and added to 100 ml of ice-cold G-buffer (2 mM 
Tris, pH 8, 0.2 mM CaCl2, 0.5 mM NaN3, 0.2 mM Na2ATP, and 0.5 mM 
DTT). The mix was slowly stirred on ice for 30 min until viscosity 
increased. The suspension was carefully transferred into polycarbonate 
centrifuge tubes for the 70Ti rotor (Beckman Coulter), topped up with 
G-buffer, and centrifuged at 20,000 g for 35 min at 4°C. The superna-
tant was filtered through two small pinches of glass wool packed into 
the neck of a funnel and then filtered with a 0.45-µm filter, followed by 
0.22-µm filters. At room temperature, a final concentration of 0.8 M 
KCl and 2 mM MgCl2 was added. The actin was stirred slowly and 
consistently for 30 min at room temperature to let it polymerize and 
then stirred gently at 4°C to dissociate contaminating tropomyosin. The 
suspension was poured into tubes for the rotor (70Ti) and centrifuged at 
45,000 rpm (80,000 g) at 4°C to sediment the F-actin. 1–2 ml G-buffer 
was added, and the pellet was gently resuspended using a Teflon-coated 
rod. The actin was homogenized and transferred to a dialysis cassette. 
The actin was dialyzed in the cold room against 1 liter of G-buffer 
and then dialyzed again overnight. Dialysis continued by changing the 
G-buffer three times, each over the next 2 d in the cold room. On day 4, 
the dialysis buffer was changed two to three times over 4 h in the morn-
ing. Then, the actin was centrifuged at 80,000 g for 2 h to sediment 
aggregates. A gel filtration column (S200) was equilibrated with fresh 
G-buffer using an FPLC, and the G-actin was applied to the column 
and repeated as needed, avoiding the lower part of the tube containing 
the pellet of actin aggregates. The fractions were run on SDS-PAGE, 
and the pure actin-containing fractions were pooled and dialyzed into 
G-buffer minus NaN3. Sucrose was added to 5% final concentration, 
and 5-ml aliquots were snap frozen, dried in a freeze dryer, and stored 
at −80°C. Cold dH2O was added to resuspend the actin, which was then 
able to be stored on ice for up to 1 mo.
Lipid protonation and liposome preparation
All lipids were purchased from Avanti Polar Lipids (natural brain lip-
ids for PC, PS, and PI(4,5)P2, and synthetic for PI(3,4)P2 and PI(3)P), 
apart from C16-NBD–labeled PI(3,4)P2 [Echelon Biosciences], which 
was a gift from P. Vecino, Tebu-Bio). Phosphoinositide powders were 
resuspended in CHCl3, dried under a stream of nitrogen, and desiccated 
for 1 h. The lipid film was resuspended with 2 CHCl3/1 MeOH/0.001 
1N HCl, incubated for 15 min, dried under nitrogen, and desiccated for 
1 h. The lipid film was then resuspended with 3 CHCl3/1 MeOH, dried 
under nitrogen, resuspended with CHCl3, dried under nitrogen, and fi-
nally resuspended with CHCl3 at 1 mg/ml and stored at −20°C. Lipo-
some samples for microscopy experiments (with a broad size distribution 
from 50 nm to 5 µm) were prepared at a 1-mM total lipid concentration 
by mixing lipid chloroform/methanol stocks as appropriate (with 0.2% 
rhodamine-PE or 0.6% NBD-PE) in a glass test tube and drying with ni-
trogen and then under vacuum for 1 h. Lipid films were resuspended in a 
sucrose solution with an osmolarity equivalent to XB buffer (204 mosM) 
and then shaken vigorously on a vortexer for 30 min at room tempera-
ture. Giant unilamellar vesicles were prepared from these samples by 
freeze/thawing in liquid nitrogen/37°C water bath five times (Traïkia et 
al., 2000), followed by gentle centrifugation to discard small liposomes 
and membrane residues. In parallel, large unilamellar vesicles and small 
unilamellar vesicles were prepared from the same sample by freeze/
thawing as above eight times, followed by extrusion 15 times, initially 
through an 800-nm polycarbonate filter and then a 50-nm polycarbonate 
filter (Mini-Extruder; Avanti Polar Lipids). The giant, large, and small 
unilamellar vesicle samples were mixed together (molar ratio 3:1:1) and 
stored at 4°C before observation. SUV samples for sedimentation assays 
and microscopy assays were prepared at a 1-mM total lipid concentration 
by mixing lipid stocks as appropriate in a glass test tube and drying with 
nitrogen and then under vacuum for 1 h. Lipid films were resuspended in 
XB buffer for sedimentation assays or a sucrose solution with an osmo-
larity equivalent to XB buffer (204 mosM) for microscopy assays and 
then shaken vigorously on a vortexer for 30 min at room temperature. Li-
posomes were prepared by freeze/thawing in liquid nitrogen/37°C water 
bath eight times followed by extrusion 15 times initially through an 800-
nm polycarbonate filter to prepare the largest liposomes and then a 100-
nm polycarbonate filter. Loss of lipids during filtering was quantified 
using SDS-PAGE and Coomassie staining, after which the lipid concen-
tration of the 100-nm vesicles was adjusted to match the 800-nm sample.
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Liposome size and surface area determination by PAI NT and analysis
Superresolution imaging was performed using a home-built TIRF mode 
based on an inverted optical microscope (IX73; Olympus) and coupled 
to an electron-multiplied charged-coupled device (EMC CD) camera 
(Evolve II 512; Photometrics). A continuous wave diode-pumped sol-
id-state laser operating at 532 nm (LAS OS; Lasertechnik GmbH) was 
used as the excitation light source to induce fluorescence in the Nile 
red molecules. The laser was prepared to circularly polarized light by 
a quarter wave plate and directed off a dichroic mirror Di02-R532-25 
× 36 for 532 nm of illumination (Semrock) through a high numerical 
aperture oil-immersion objective lens (Plan Apochromat 60× NA 1.49; 
APON 60× OTI RF; Olympus) to the sample coverslip. Total internal 
reflection was achieved by focusing the laser at the back focal plane 
of the objective, off axis, such that the emergent beam at the sample 
interface was near collimated and incident at an angle greater than the 
critical angle θc ∼67° for a glass/water interface for TIRF imaging. 
This generated an ∼50-µm diameter excitation footprint with power 
densities in the range of ∼0.5 kWcm−2 at the coverslip. The emitted 
fluorescence was collected through the same objective and further fil-
tered using a longpass filter (BLP01-532R-25; Semrock), a bandpass 
filter (FF01-650/200-25; Semrock), and a shortpass filter (FF01-715/
SP-25; Semrock) for 532 nm of illumination before being expanded 
by a 2.5× relay lens (PE 2.5× 125; Olympus). The fluorescence image 
was captured on the EMC CD camera running in frame transfer mode at 
20 Hz, with an electron multiplication gain of 250, operating at −70°C 
with a pixel size of 16 µm and automated using the open source micros-
copy platform Micromanager. Nile red (N1142; Thermo Fisher Scien-
tific) stock solutions were prepared by dissolving Nile red into DMSO 
(D2650 >99.7% purity) to a concentration of 1 mM. The stock solution 
was divided into 10-µl aliquots, flash frozen in liquid N2, and stored in 
the dark at −80°C until required. For a working solution, the aliquot 
was diluted into the filtered XB buffer to a final concentration of 50 
nM. For the observation chamber, glass coverslips (0.13-mm thickness, 
22 × 22 mm, VWR collection, 631–0124) were cleaned by using an 
argon plasma cleaner (PDC-002; Harrick Plasma) for at least 1 h. After 
that, frame-seal slide chambers (9 × 9 mm; BioRad) were firmly af-
fixed to the cleaned glass coverslips. The chamber was covered with 
poly-l-lysine solution (0.01% wt/vol, P4832-50ML) to fully coat the 
coverglass surface, incubated for 30 min, and then washed at least four 
times with the filtered XB buffer. After that, the chamber was covered 
by the filtered XB buffer to prevent any contaminations of the covers-
lip’s surface until loaded with the liposome samples. To determine the 
liposome size, 500 nM (100-nm liposomes) and 1 µM (250-nm lipo-
somes) concentrations were added to the chamber and incubated for 10 
min, and then 1 µl of the working Nile red solution (50 nM) was added 
to the chamber to a final concentration of 1 nM. Superresolution images 
of 100-nm and 250-nm liposomes on a glass surface were observed 
during 2,000 frames at a frame rate of 20 ms. Nile red localizations 
in the image were determined using the Peak Fit plugin for ImageJ 
(National Institutes of Health). Individual liposome diameters in the su-
perresolution image were determined by calculating the full width half 
maximum (FWHM) from the standard deviation of a two-dimensional 
Gaussian fit. With the FWHM value, we calculated the surface area (A) 
of individual liposomes using the equation 
  A  =  4  πr 2   ≈  4π  ( FWHM ______2 ) 
2
 . 
Liposome size determination by dynamic light scattering
Liposome samples were measured by dynamic light scattering using 
a molecular size analyzer (Zetasizer Nano ZS; Malvern Instruments), 
with liposomes at a 150-mM final concentration in XB buffer. The size 
distribution output in intensity was converted into number distribution 
using the Zetasizer software transformation method, with the following 
parameters: shell refractive index at 1.43, particle core refractive index 
at 1.33, and core radius/shell ratio at 20 for 400-nm extruded liposomes 
and 10 for 100-nm extruded liposomes. Samples were stored on ice 
before sedimentation assays.
Liposome in vitro imaging and analysis
The observation chamber was prepared by adding a 50-µl drop of 5% 
BSA solution (wt/vol, in water, filter with 0.22-µm membranes) to a 
silicon gasket on a coverslip and incubating for 1 h, after which the 
area was extensively rinsed with XB buffer. To test for SNX9 binding, 
45 µl of XB was applied to the chamber, followed by 3 µl liposome mix 
(rhodamine-PE labeled), which was left for 5–10 min to sediment, after 
which 125 nM (final) Alexa Fluor 647–SNAP-SNX9 was slowly in-
jected on top of the sample, and several representative regions were im-
aged (immediately after injection). To test for actin polymerization in 
the presence of frog egg extract, 22 µl XB was applied to the chamber, 
followed by 3 µl liposome mix, which was left to sediment for 5–10 
min. 35 µl of reaction mix was prepared in XB containing (final assay 
concentration after addition to liposome mix) energy mix (5.25 mM 
phosphocreatine, 0.7 mM ATP, 0.7 mM MgCl2, pH 7, 2 mM DTT, 3.5 
mg/ml HSS frog egg extract, 0.8 mM unlabeled actin, 0.3 mM Alexa 
Fluor 647–labeled actin, and ±100 nM SNX9). These were added to 
the sample, and several representative regions were imaged after 10 
min of incubation. To test the activity of the phosphatase INPP4A, 
the same protocol was used, except that liposome samples were pre-
incubated with the enzyme before sedimentation (20 nM final; 1 h at 
25°C in the dark). To examine actin polymerization in the presence of 
the minimal purified system, 21  µl XB was applied to the chamber, 
followed by 3 µl liposome mix, which was left to sediment for 5–10 
min, after which a final assay concentration of 50 nM GTP-γS–loaded 
Cdc42 was gently added on top of the sample. 25-µl reaction mixes 
were prepared in XB containing (final assay concentration) 0.2  mM 
ATP, 2  mM DTT, 8  µM unlabeled actin, 0.3  µM Alexa Fluor 647– 
labeled actin, 50 nM X. laevis Arp2/3 complex, 100 nM SNX9, and 100 
nM N-WASP–WIP and were added to the sample, and several repre-
sentative regions were imaged after 10 min of incubation. Images were 
analyzed using MetaMorph software.
Sedimentation assays
For SNX9 (WT and mutants), SNX2, SNX4, SNX5, SNX8, SNX18, 
and SNX33, 20 µl liposomes (1 mM total lipid) was mixed with pro-
teins (1.5 µM final) in a 100-µl final volume of XB. These were incu-
bated for 20 min at room temperature, followed by ultracentrifugation 
at 120,000 g (TLA-100 rotor; Beckman Coulter). For Cdc42 activation, 
25 µl liposomes (1 mM) were mixed with HSS (3.5 mg/ml final) and 
mKate GBD (10 nM final). These were incubated for 15 min at room 
temperature, followed by ultracentrifugation at 120,000  g.  Superna-
tants and pellets (resuspended in 100 µl XB) were collected and ana-
lyzed by SDS-PAGE Coomassie staining (SNX9) or Western blotting 
(mKate-GBD). Quantification was performed using the LI-COR imag-
ing system and Image Studio software.
INPP4A phosphatase thin-layer chromatography (TLC) assay
Silica TLC plates (Merck Millipore) were preimpregnated in a solu-
tion of 2  mM EDTA and 1% potassium oxalate/MeOH (2:3). 48% 
PC/47.5% PS/4% PI(3,4)P2/0.5% C16-NBD PI(3,4)P2 liposomes were 
prepared to a 2-mM total lipid concentration and extruded through 100-
nm or 800-nm polycarbonate filters. The 800-nm extruded population 
had a mean diameter of 250 nm. 110 µl of each liposome suspension 
was incubated with 10 nM INPP4A at room temperature in the dark 
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in a buffer containing 150 mM NaCl, 20 mM Hepes, pH 7.4, 2 mM 
EDTA, and 5 mM CaCl2. 10-µl samples were taken after 0, 1, 2, 5, 10, 
20, 30, 60, 90, 120, and 150 min and immediately boiled to inactivate 
the enzyme. For each time point sample, lipids were extracted by add-
ing 10 µl chloroform, shaking vigorously, and the organic phase was 
collected. The extraction was repeated, and the organic phases were 
pooled, with 10 µl lipid solution in chloroform for each time point spot-
ted on a TLC plate. The plate was eluted with 65% propan-1-ol/35% 
2 M acetic acid for several hours in the dark, after which the plates were 
read on a phosphorimager (Fujifilm) with the band intensity analyzed 
using the gel tool in ImageJ. Graphs were made in Excel (Microsoft).
Pyrene actin assays
Pyrene actin assays were performed using the purified minimal recon-
stituted system based on a previous protocol (Ho et al., 2006). Actin 
was purified as previously described (Pardee and Spudich, 1982). 100-
µl assay mixes were prepared in a quartz cuvette by adding components 
in the following order: 10× assay buffer (500 mM KCl, 100 mM Hepes, 
pH 7.4, 20 mM MgCl2, 0.2 mM ATP, and 2 mM DTT),100 µM (total 
lipid concentration) liposomes, 500 nM Q61L Cdc42, 100 nM SNX9, 
100 nM N-WASP–WIP, and 50 nM bovine Arp2/3 complex, with reac-
tions started by the addition of a 67% unlabeled/33% pyrene actin mix 
at a final actin concentration of 1.2 µM. For each series of experiments, 
a negative control of background actin polymerization in assay buffer 
and a positive control of using GST-VCA to activate the Arp2/3 com-
plex were performed. Polymerization curves were collected on a spec-
trophotometer (FluoroMax-4; Horiba Scientific) and analyzed in Excel.
Transmission EM
Samples were prepared as for the liposome minimal purified system 
microscopy assay and verified for actin aster formation by fluorescence 
microscopy immediately before negative staining. Small drops of sam-
ples were dotted onto dental film and glow discharged, and formvar-car-
bon–coated EM grids (provided by the Cambridge Advanced Imaging 
Centre, University of Cambridge) were inverted onto the samples for 2 
min, after which they were quickly spotted on filter paper and imme-
diately transferred to a spot of 3% aqueous uranyl acetate for 1 min. 
Excess negative stain was removed with filter paper, and the grids were 
allowed to dry before imaging on a transmission electron microscope 
(Tecnai G2; 80–200 kv). Images were cropped in Photoshop (Adobe).
Fluorescence microscopy
For liposome in vitro analysis, confocal images were acquired on an in-
verted microscope (Ti-E; Nikon) equipped with spinning-disk (X-light 
Nipkow; Crest), 250-µm piezo-driven Z stage/controller (NanoScanZ) 
and Lumencor Spectra X LED illumination using a 100× 1.40 oil objec-
tive (Plan Apo VC; Nikon). Images were collected at room temperature 
with an EMC CD (Evolve Delta; Photometrics) camera in 16-bit depth 
using Metamorph software version 7.8.2.0. Alexa Fluor 488, 568, and 
647 samples were visualized using 470/40, 560/25, and 628/40 exci-
tation and 525/50, 585/50, and 700/75 emission filters, respectively. 
Live-cell imaging of actin comets in RPE-1 cells was performed on 
the same microscope supplemented with a stage top heated chamber 
(Okolabs) at 37°C. Cells were grown in glass-bottomed dishes (Ibidi), 
transfected as outlined above, and imaged in phenol red–free media 
containing 20  mM Hepes, pH 7.4.  Confocal imaging of immunola-
beled cells was performed on a laser-scanning microscope (FV1000; 
Olympus) using a 100× UPlanSApo 1.4 oil objective controlled by 
FV10-ASW software version 4.2. Alexa Fluor 488, 568, and 647 sam-
ples were imaged at room temperature using laser excitation lines at 
488, 561, or 635 nm and the standard FV1000 photomultiplier tube 
detectors with emission windows set to 500–545 nm, 570–625 nm, and 
655–755 nm, respectively. For live-cell imaging of CME in HeLa cells, 
cells were grown and transfected according to standard protocols on 
uncoated MatTek dishes. Experiments were conducted using a growth 
chamber (37°C, 5% CO2) in connection with an A1 R laser-scanning 
confocal microscope system with an EMC CD camera (AND OR iXon; 
Nikon Instruments) under control of the NIS-Elements microscope im-
aging software, allowing real-time TIRF acquisitions with a 100× lens 
(Apochromat 1.49 oil 0.13–0.20 DIC N2; Nikon).
Analysis of CME in HeLa cells
The representative microscopic images viewed in the figures were drift 
corrected using ImageJ and prepared (cropped, rotated and linearly 
adjusted for intensity) using Photoshop CS5. Spots of GFP-SNX9 or 
clathrin-Lca-mCherry after siRNA transfection were evaluated by ana-
lyzing TIRF live-cell acquisitions (800 ms between frames, over 193 s) 
using the Imaris software V7.5 (Bitplane), tracking mode. A region of 
interest sized 100 × 100 pixels (256 µm2) was segmented for spots using 
an estimated diameter of 0.4 µm, background subtraction, a filter using 
a quality threshold >102, Brownian motion, maximum distance of 0.7 
µm, maximum gap size of 1, no fill gap, and a track duration minimum 
of 32 s. Graphs were made in Excel and Prism (GraphPad). Analysis 
of persistent CCPs and endocytic lifetimes was performed in MatLab 
(MathWorks) using custom-written software (Aguet et al., 2013). The 
latest software is available for download from M. Mettlen. In brief, the 
analysis focuses on diffraction-limited objects, and the detection of all 
clathrin-labeled structures is based on the assumption that all relevant 
fluorescent signals can be described by a Gaussian point spread func-
tion. Signals were selected as valid detections if their amplitude was 
higher than a 95th percentile confidence threshold in the local back-
ground noise distribution. Fluorescent trajectories were automatically 
calculated from the detections obtained in individual frames, and bona 
fide CCPs that undergo stabilization and maturation were distinguished 
from transient subthreshold clathrin-labeled structures based on quan-
titative analysis of the progression of their fluorescence intensity during 
early stages of growth, as previously described (Aguet et al., 2013). 
The lifetimes (i.e., time elapsed between first and last detection of a 
given trajectory) of these bona fide CCPs were then extracted and plot-
ted. Tracks were categorized as persistent if their diffraction-limited 
fluorescent signal was present throughout the entire acquisition period 
(i.e., present in the first and last frames of the time lapse).
Transferrin internalization assay
Flp-In TRex GFP-SNX9 HeLa cells were treated with 60 nM stealth 
siRNA (Invitrogen) for 72 h before uptake. The day before the assay, 
105 cells/well were seeded on coverslips in 24-well plates and induced 
with 1 ng/ml doxycycline (Sigma-Aldrich). Cells were pretreated with 
1 µM latrunculin A (Sigma-Aldrich) or DMSO in medium for 10 min 
at 37°C immediately before addition of transferrin. Medium with 8 
µg/ml 650-s-s-transferrin together with DMSO or 1 µM latrunculin A 
was then added to each well. After a 10-min incubation at 37°C, the 
medium was removed and cells were quickly washed once with PBS 
followed by cell fixation for 20 min with 3% PFA in PBS at room tem-
perature. Cells were then washed once in 4°C stripping buffer (100 mM 
NaCl, 50  mM Tris-HCl, and 2.5  mM CaCl2, pH 8.7) and incubated 
two times for 20 min with freshly prepared 100 mM Mesna (Sigma- 
Aldrich) in stripping buffer. Cells were then incubated with 1:25,000 
DAPI in PBS for 15 min and mounted for microscopy. Z stacks of the 
samples were imaged with a spinning-disk confocal live-cell imaging 
system (Cell Observer; Zeiss), controlled by ZEN interface with an 
inverted microscope (Observer.Z1; Axio) and equipped with a spin-
ning-disk unit (CSU-X1A 5000) and an EMC CD camera (iXon Ultra; 
AND OR). Endosomes were segmented as spots using IMA RIS. Total 
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intensity of detected endosomes in the Z stacks was divided by the 
amount of cells in the image (DAPI). Data were prepared, analyzed, 
and presented in Excel and Prism.
Tracking analysis of actin comets in RPE-1 OCRL KO cells
Images were captured as a small Z series (4 × 0.2 µm), taken every 2 s 
over a 4-min period. Representative images and videos show a maximal 
projection of this Z stack and were prepared in FIJI (ImageJ). FIJI was 
also used to create the temporally color-coded images; the representative 
videos were bleach corrected, and a maximal projection of the Z stack 
was created. Background subtraction was performed by creating a mean 
intensity projection of the entire time course and subtracting this from 
each individual frame. The resulting stack was fed into the Temporal 
Color-Code plug-in using the ice LUT to create the images presented.
Comet tracking analysis was performed using the Trackmate 
plug-in in FIJI. Images were blinded before analysis and then processed 
to isolate moving comets and allow the plug-in to detect them. Each 
image was converted to a Z series maximal projection. The triangle 
threshold function was used to identify cells in the image, followed 
by an erosion function to remove outer processes (such as filopodia or 
membrane ruffling, which the plug-in could detect as motile puncta and 
attempt to track). This region was isolated, and the area of interest was 
recorded. After this, a stack of the difference between adjacent frames in 
this isolated region was created to isolate objects that had moved. This 
was analyzed using the Trackmate plug-in. Images were analyzed using 
the LoG detector with the median filter and subpixel localization turned 
on. Spots representing comet heads were detected using an estimated 
blob diameter of 0.75 µm, and an appropriate threshold was set manually. 
Identified blobs were determined as comets by tracking their movement 
using the Simple LAP tracker, using a maximum linking distance of 2.4 
µm (determined by manually tracking a selection of control comets from 
several reference cells), with no gap closing. Detected tracks were cate-
gorized as comets when they persisted for 8 s or longer (five consecutive 
frames), with the number detected for each region recorded. The dura-
tion, track displacement, and mean track speed for all the comets in the 
image were also recorded. For data analysis, each cell region represents 
the number of comets detected in an individual image. These normally 
come from a single cell, but can include more than one cell when neigh-
boring cells are also expressing F-tractin and therefore included after 
the thresholding step, with the data expressed as the number of tracks 
detected/thresholded area (micrometers squared)/total time (minutes). 
Graphs and statistical analysis were prepared using Prism software.
Immunolabeling of RPE-1 OCRL KO cells
Cells grown on coverslips were fixed based on the Golgi fixation pro-
tocol outlined by Hammond et al. (2009). Washes were performed be-
tween each step. Cells were fixed in 2% PFA (Thermo Fisher Scientific) 
in PBS for 15 min and permeabilized in 20 µM digitonin (Sigma-Al-
drich) in buffer A (150 mM NaCl, 20 mM Hepes, pH 7.4, and 2 mM 
EDTA) for 5 min. Cells were blocked in 5% goat serum (in buffer A; 
Sigma-Aldrich) for 45 min and then treated with primary antibody for 
1 h (in 0.5% goat serum in buffer A), followed by secondary antibody 
for 30 min, before being postfixed in 2% PFA for 5 min. Coverslips were 
mounted onto slides using Hydromount (National Diagnostics). To label 
PI(3)P, purified mCherry-2×FYVE was added during the blocking step 
at a final concentration of 1 µg/ml and then immunolabeled using an 
RFP primary antibody and Alexa Fluor 568 secondary antibody. Images 
were captured as a laser-scanning confocal Z series (10 × 0.2 µm) and 
are displayed as a maximal projection of this stack, prepared in FIJI.
OCRL actin comet inhibitor treatments
Wortmannin (Sigma-Aldrich) and Vps34-IN1 (Selleck Chemicals) 
were made up in DMSO at 2- and 10-mM stock concentrations, re-
spectively. Cells were treated with wortmannin at a final concentration 
of 2 µM, Vps34-IN1 at 10 µM, and DMSO at an appropriate 1:1,000 
dilution in serum-free media 1 h before analysis.
Online supplemental material
Fig. S1 shows the SDS-PAGE of protein purifications for the reconsti-
tution. Fig. S2 shows Western blots and gels of the SNX9 binding data 
and control showing sedimentation, and floatation assays give similar 
data. Fig. S3 has example pictures and the quantifications of liposome 
size from PAI NT and dynamic light-scattering experiments. Fig. S4 
shows control experiments for the effect of INPP4A depletion on endo-
cytosis in HeLa cells. Fig. S5 illustrates how the OCRL CRI SPR KO 
cells were made and control experiments for analysis of actin comet 
tails in these cells. Videos 1 and 2 show SNX9 and clathrin spots in 
control and INPP4A siRNA–treated HeLa cells. Videos 3 and 4 show 
actin comet tails in control, OCRL KO, and rescue RPE cells. Videos 5 
and 6 show actin comet tails on INPP4A siRNA or inhibitor treatment.
Acknowledgments
We would like to thank the Biochemical Imaging Centre Umeå and 
Maria Teresa Vidal-Quadras for help with the imaging processing and 
presentation, the Protein Expertise Platform at Chemical Biological 
Centre, Umeå University, for help with cloning INPP4A, Matylda Scza-
niecka-Clift from the Gurdon Institute for assistance with OCRL CRI SPR/
Cas9 implementation, Andy Riddell at the flow cytometry core facility 
of the Stem Cell Institute, and Richard Butler from the Gurdon Institute 
core imaging facility for help with actin comet tracking. We also thank 
Sandra Schmid, Brigid Hogan, and Daniel St Johnston for critical 
reading of the manuscript. The EM was conducted at the Cambridge 
Advanced Imaging Centre.
J.L. Gallop is supported by a Wellcome Trust Research Career 
Development Fellowship (grant WT095829AIA). F.  Daste, A.  Wal-
rant, J.R. Gadsby, and J. Mason are supported by an H2020 Euro-
pean Research Council Starting Grant (281971) awarded to 
J.L. Gallop. Gurdon Institute funding is provided by the Wellcome Trust 
(grant 092096) and Cancer Research UK (grant C6946/A14492). 
The Swedish Medical Research Council and the Swedish Foundation 
for Strategic Research supported the work of M.R. Holst and R. Lund-
mark. S.F. Lee is funded by a Royal Society University Research Fellow-
ship (grant UF120277). M. Mettlen is funded by grant MH73125 to 
Sandra L. Schmid (University of Texas Southwestern Medical Center). 
The authors declare no competing financial interests.
Author contributions: F. Daste and A. Walrant performed the in 
vitro liposome and actin experiments assisted by J.R.  Gadsby and 
D. Brook. M.R. Holst and E. Larsson performed the CME experiments 
supervised by R. Lundmark, and M. Mettlen measured CCP lifetimes. 
J.R.  Gadsby performed the OCRL deficiency cell experiments. 
J. Mason performed cell culture and molecular biology to make con-
structs and prepare proteins. J.-E.  Lee and S.F.  Lee performed and 
analyzed the PAI NT experiments. J.L. Gallop conceived of and coordi-
nated the project and wrote the paper assisted by all authors.
Submitted: 7 April 2017
Revised: 6 July 2017
Accepted: 4 August 2017
 o
n
 O
ctober 2, 2017
jcb.rupress.org
D
ow
nloaded from
 
JCB﻿﻿  • 201720
References
Aghamohammadzadeh, S., and K.R. Ayscough. 2009. Differential requirements 
for actin during yeast and mammalian endocytosis. Nat. Cell Biol. 
11:1039–1042. http ://dx .doi .org /10 .1038 /ncb1918
Aguet, F., C.N.  Antonescu, M.  Mettlen, S.L.  Schmid, and G.  Danuser. 2013. 
Advances in analysis of low signal-to-noise images link dynamin and 
AP2 to the functions of an endocytic checkpoint. Dev. Cell. 26:279–291. 
http ://dx .doi .org /10 .1016 /j .devcel .2013 .06 .019
Bago, R., N.  Malik, M.J.  Munson, A.R.  Prescott, P.  Davies, E.  Sommer, 
N.  Shpiro, R.  Ward, D.  Cross, I.G.  Ganley, and D.R.  Alessi. 2014. 
Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals 
that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase 
is a downstream target of class III phosphoinositide 3-kinase. Biochem. 
J. 463:413–427. http ://dx .doi .org /10 .1042 /BJ20140889
Bendris, N., C.J.  Stearns, C.R.  Reis, J.  Rodriguez-Canales, H.  Liu, 
A.W.  Witkiewicz, and S.L.  Schmid. 2016. Sorting nexin 9 negatively 
regulates invadopodia formation and function in cancer cells. J. Cell Sci. 
129:2804–2816. http ://dx .doi .org /10 .1242 /jcs .188045
Billcliff, P.G., C.J. Noakes, Z.B. Mehta, G. Yan, L. Mak, R. Woscholski, and 
M.  Lowe. 2016. OCRL1 engages with the F-BAR protein pacsin 2 to 
promote biogenesis of membrane-trafficking intermediates. Mol. Biol. 
Cell. 27:90–107. http ://dx .doi .org /10 .1091 /mbc .E15 -06 -0329
Bökenkamp, A., and M.  Ludwig. 2016. The oculocerebrorenal syndrome of 
Lowe: an update. Pediatr. Nephrol. 31:2201–2212. http ://dx .doi .org /10 
.1007 /s00467 -016 -3343 -3
Boulant, S., C.  Kural, J.C.  Zeeh, F.  Ubelmann, and T.  Kirchhausen. 2011. 
Actin dynamics counteract membrane tension during clathrin-mediated 
endocytosis. Nat. Cell Biol. 13:1124–1131. http ://dx .doi .org /10 .1038 /
ncb2307
Carlton, J., M.  Bujny, A.  Rutherford, and P.  Cullen. 2005. Sorting nexins--
unifying trends and new perspectives. Traffic. 6:75–82. http ://dx .doi .org 
/10 .1111 /j .1600 -0854 .2005 .00260 .x
Cauvin, C., M.  Rosendale, N.  Gupta-Rossi, M.  Rocancourt, P.  Larraufie, 
R.  Salomon, D.  Perrais, and A.  Echard. 2016. Rab35 GTPase triggers 
switch-like recruitment of the Lowe syndrome lipid phosphatase OCRL 
on newborn endosomes. Curr. Biol. 26:120–128. http ://dx .doi .org /10 
.1016 /j .cub .2015 .11 .040
Chang-Ileto, B., S.G. Frere, R.B. Chan, S.V. Voronov, A. Roux, and G. Di Paolo. 
2011. Synaptojanin 1-mediated PI(4,5)P2 hydrolysis is modulated by 
membrane curvature and facilitates membrane fission. Dev. Cell. 20:206–
218. http ://dx .doi .org /10 .1016 /j .devcel .2010 .12 .008
Chiang, T.W., C.  le Sage, D. Larrieu, M. Demir, and S.P. Jackson. 2016. CRI 
SPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to 
enhance genome editing. Sci. Rep. 6:24356. http ://dx .doi .org /10 .1038 /
srep24356
Ferguson, S.M., A. Raimondi, S. Paradise, H. Shen, K. Mesaki, A. Ferguson, 
O. Destaing, G. Ko, J. Takasaki, O. Cremona, et al. 2009. Coordinated 
actions of actin and BAR proteins upstream of dynamin at endocytic 
clathrin-coated pits. Dev. Cell. 17:811–822. http ://dx .doi .org /10 .1016 /j 
.devcel .2009 .11 .005
Fujimoto, L.M., R. Roth, J.E. Heuser, and S.L. Schmid. 2000. Actin assembly 
plays a variable, but not obligatory role in receptor-mediated endocytosis 
in mammalian cells. Traffic. 1:161–171. http ://dx .doi .org /10 .1034 /j .1600 
-0854 .2000 .010208 .x
Gallop, J.L., A.  Walrant, L.C.  Cantley, and M.W.  Kirschner. 2013. 
Phosphoinositides and membrane curvature switch the mode of actin 
polymerization via selective recruitment of toca-1 and Snx9. Proc. 
Natl. Acad. Sci. USA. 110:7193–7198. http ://dx .doi .org /10 .1073 /pnas 
.1305286110
Grassart, A., A.T. Cheng, S.H. Hong, F. Zhang, N. Zenzer, Y. Feng, D.M. Briner, 
G.D.  Davis, D.  Malkov, and D.G.  Drubin. 2014. Actin and dynamin2 
dynamics and interplay during clathrin-mediated endocytosis. J.  Cell 
Biol. 205:721–735. http ://dx .doi .org /10 .1083 /jcb .201403041
Hammond, G.R., G.  Schiavo, and R.F.  Irvine. 2009. Immunocytochemical 
techniques reveal multiple, distinct cellular pools of PtdIns4P and 
PtdIns(4,5)P(2). Biochem. J.  422:23–35. http ://dx .doi .org /10 .1042 /
BJ20090428
Ho, H.Y., R.  Rohatgi, A.M.  Lebensohn, J.  Le Ma, J.  Li, S.P.  Gygi, and 
M.W.  Kirschner. 2004. Toca-1 mediates Cdc42-dependent actin 
nucleation by activating the N-WASP-WIP complex. Cell. 118:203–216. 
http ://dx .doi .org /10 .1016 /j .cell .2004 .06 .027
Ho, H.Y., R.  Rohatgi, A.M.  Lebensohn, and M.W.  Kirschner. 2006. In vitro 
reconstitution of cdc42-mediated actin assembly using purified 
components. Methods Enzymol. 406:174–190. http ://dx .doi .org /10 .1016 
/S0076 -6879(06)06014 -9
Hsu, P.D., D.A. Scott, J.A. Weinstein, F.A. Ran, S. Konermann, V. Agarwala, 
Y. Li, E.J. Fine, X. Wu, O. Shalem, et al. 2013. DNA targeting specificity 
of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31:827–832. http ://dx 
.doi .org /10 .1038 /nbt .2647
Hübner, S., A.D. Couvillon, J.A. Käs, V.A. Bankaitis, R. Vegners, C.L. Carpenter, 
and P.A. Janmey. 1998. Enhancement of phosphoinositide 3-kinase (PI 
3-kinase) activity by membrane curvature and inositol-phospholipid-
binding peptides. Eur. J.  Biochem. 258:846–853. http ://dx .doi .org /10 
.1046 /j .1432 -1327 .1998 .2580846 .x
Itoh, T., K.S. Erdmann, A. Roux, B. Habermann, H. Werner, and P. De Camilli. 
2005. Dynamin and the actin cytoskeleton cooperatively regulate plasma 
membrane invagination by BAR and F-BAR proteins. Dev. Cell. 9:791–
804. http ://dx .doi .org /10 .1016 /j .devcel .2005 .11 .005
Ivetac, I., A.D.  Munday, M.V.  Kisseleva, X.M.  Zhang, S.  Luff, T.  Tiganis, 
J.C.  Whisstock, T.  Rowe, P.W.  Majerus, and C.A.  Mitchell. 2005. 
The type Ialpha inositol polyphosphate 4-phosphatase generates and 
terminates phosphoinositide 3-kinase signals on endosomes and the 
plasma membrane. Mol. Biol. Cell. 16:2218–2233. http ://dx .doi .org /10 
.1091 /mbc .E04 -09 -0799
Lebensohn, A.M., L. Ma, H.Y. Ho, and M.W. Kirschner. 2006. Cdc42 and PI(4,5)
P2-induced actin assembly in Xenopus egg extracts. Methods Enzymol. 
406:156–173. http ://dx .doi .org /10 .1016 /S0076 -6879(06)06013 -7
Lewellyn, E.B., R.T. Pedersen, J. Hong, R. Lu, H.M. Morrison, and D.G. Drubin. 
2015. An Engineered Minimal WASP-Myosin Fusion Protein Reveals 
Essential Functions for Endocytosis. Dev. Cell. 35:281–294. http ://dx .doi 
.org /10 .1016 /j .devcel .2015 .10 .007
Li, D., L.  Shao, B.C.  Chen, X.  Zhang, M.  Zhang, B.  Moses, D.E.  Milkie, 
J.R. Beach, J.A. Hammer III, M. Pasham, et al. 2015. ADV ANC ED IMA 
GING. Extended-resolution structured illumination imaging of endocytic 
and cytoskeletal dynamics. Science. 349:aab3500. http ://dx .doi .org /10 
.1126 /science .aab3500
Lundmark, R., and S.R. Carlsson. 2003. Sorting nexin 9 participates in clathrin-
mediated endocytosis through interactions with the core components. 
J.  Biol. Chem. 278:46772–46781. http ://dx .doi .org /10 .1074 /jbc 
.M307334200
Lundmark, R., and S.R. Carlsson. 2009. SNX9 - a prelude to vesicle release. 
J. Cell Sci. 122:5–11. http ://dx .doi .org /10 .1242 /jcs .037135
Martens, S., M.M.  Kozlov, and H.T.  McMahon. 2007. How synaptotagmin 
promotes membrane fusion. Science. 316:1205–1208. http ://dx .doi .org 
/10 .1126 /science .1142614
Michelot, A., and D.G. Drubin. 2011. Building distinct actin filament networks 
in a common cytoplasm. Curr. Biol. 21:R560–R569. http ://dx .doi .org /10 
.1016 /j .cub .2011 .06 .019
Mooren, O.L., B.J. Galletta, and J.A. Cooper. 2012. Roles for actin assembly in 
endocytosis. Annu. Rev. Biochem. 81:661–686. http ://dx .doi .org /10 .1146 
/annurev -biochem -060910 -094416
Nández, R., D.M. Balkin, M. Messa, L. Liang, S. Paradise, H. Czapla, M.Y. Hein, 
J.S.  Duncan, M.  Mann, and P.  De Camilli. 2014. A role of OCRL in 
clathrin-coated pit dynamics and uncoating revealed by studies of Lowe 
syndrome cells. eLife. 3:e02975. http ://dx .doi .org /10 .7554 /eLife .02975
Pardee, J.D., and J.A.  Spudich. 1982. Purification of muscle actin. Methods 
Enzymol. 85:164–181. http ://dx .doi .org /10 .1016 /0076 -6879(82)85020 -9
Pasquier, B., Y.  El-Ahmad, B.  Filoche-Rommé, C.  Dureuil, F.  Fassy, 
P.Y.  Abecassis, M.  Mathieu, T.  Bertrand, T.  Benard, C.  Barrière, et 
al. 2015. Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-
methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]
pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the 
treatment of solid tumors. J. Med. Chem. 58:376–400. http ://dx .doi .org 
/10 .1021 /jm5013352
Picco, A., M. Mund, J. Ries, F. Nédélec, and M. Kaksonen. 2015. Visualizing the 
functional architecture of the endocytic machinery. eLife. 4:4. http ://dx 
.doi .org /10 .7554 /eLife .04535
Posor, Y., M.  Eichhorn-Gruenig, D.  Puchkov, J.  Schöneberg, A.  Ullrich, 
A.  Lampe, R.  Müller, S.  Zarbakhsh, F.  Gulluni, E.  Hirsch, et al. 
2013. Spatiotemporal control of endocytosis by phosphatidylinositol-
3,4-bisphosphate. Nature. 499:233–237. http ://dx .doi .org /10 .1038 /
nature12360
Pylypenko, O., R. Lundmark, E. Rasmuson, S.R. Carlsson, and A. Rak. 2007. 
The PX-BAR membrane-remodeling unit of sorting nexin 9.  EMBO 
J. 26:4788–4800. http ://dx .doi .org /10 .1038 /sj .emboj .7601889
Rodon, J., R.  Dienstmann, V.  Serra, and J.  Tabernero. 2013. Development of 
PI3K inhibitors: lessons learned from early clinical trials. Nat. Rev. Clin. 
Oncol. 10:143–153. http ://dx .doi .org /10 .1038 /nrclinonc .2013 .10
Saarikangas, J., H.  Zhao, and P.  Lappalainen. 2010. Regulation of the actin 
cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol. 
Rev. 90:259–289. http ://dx .doi .org /10 .1152 /physrev .00036 .2009
Schöneberg, J., M.  Lehmann, A.  Ullrich, Y.  Posor, W.T.  Lo, G.  Lichtner, 
J. Schmoranzer, V. Haucke, and F. Noé. 2017. Lipid-mediated PX-BAR 
domain recruitment couples local membrane constriction to endocytic 
 o
n
 O
ctober 2, 2017
jcb.rupress.org
D
ow
nloaded from
 
Membrane microenvironment in actin polymerization • Daste et al. 21
vesicle fission. Nat. Commun. 8:15873. http ://dx .doi .org /10 .1038 /
ncomms15873
Sharonov, A., and R.M. Hochstrasser. 2006. Wide-field subdiffraction imaging 
by accumulated binding of diffusing probes. Proc. Natl. Acad. Sci. USA. 
103:18911–18916. http ://dx .doi .org /10 .1073 /pnas .0609643104
Shin, H.W., M.  Hayashi, S.  Christoforidis, S.  Lacas-Gervais, S.  Hoepfner, 
M.R. Wenk, J. Modregger, S. Uttenweiler-Joseph, M. Wilm, A. Nystuen, 
et al. 2005. An enzymatic cascade of Rab5 effectors regulates 
phosphoinositide turnover in the endocytic pathway. J.  Cell Biol. 
170:607–618. http ://dx .doi .org /10 .1083 /jcb .200505128
Skau, C.T., and C.M. Waterman. 2015. Specification of architecture and function 
of actin structures by actin nucleation factors. Annu. Rev. Biophys. 
44:285–310. http ://dx .doi .org /10 .1146 /annurev -biophys -060414 -034308
Sochacki, K.A., A.M. Dickey, M.P. Strub, and J.W. Taraska. 2017. Endocytic 
proteins are partitioned at the edge of the clathrin lattice in mammalian 
cells. Nat. Cell Biol. 19:352–361. http ://dx .doi .org /10 .1038 /ncb3498
Soulet, F., D.  Yarar, M.  Leonard, and S.L.  Schmid. 2005. SNX9 regulates 
dynamin assembly and is required for efficient clathrin-mediated 
endocytosis. Mol. Biol. Cell. 16:2058–2067. http ://dx .doi .org /10 .1091 /
mbc .E04 -11 -1016
Suchy, S.F., and R.L. Nussbaum. 2002. The deficiency of PIP2 5-phosphatase 
in Lowe syndrome affects actin polymerization. Am. J.  Hum. Genet. 
71:1420–1427. http ://dx .doi .org /10 .1086 /344517
Takano, K., K. Toyooka, and S. Suetsugu. 2008. EFC/F-BAR proteins and the 
N-WASP-WIP complex induce membrane curvature-dependent actin 
polymerization. EMBO J. 27:2817–2828. (published erratum appears in 
EMBO J. 2008. 27:3332) http ://dx .doi .org /10 .1038 /emboj .2008 .216
Taylor, M.J., D. Perrais, and C.J. Merrifield. 2011. A high precision survey of the 
molecular dynamics of mammalian clathrin-mediated endocytosis. PLoS 
Biol. 9:e1000604. http ://dx .doi .org /10 .1371 /journal .pbio .1000604
Traïkia, M., D.E.  Warschawski, M.  Recouvreur, J.  Cartaud, and P.F.  Devaux. 
2000. Formation of unilamellar vesicles by repetitive freeze-thaw cycles: 
characterization by electron microscopy and 31P-nuclear magnetic 
resonance. Eur. Biophys. J.  29:184–195. http ://dx .doi .org /10 .1007 /
s002490000077
Tsujita, K., S. Suetsugu, N. Sasaki, M. Furutani, T. Oikawa, and T. Takenawa. 
2006. Coordination between the actin cytoskeleton and membrane 
deformation by a novel membrane tubulation domain of PCH proteins is 
involved in endocytosis. J. Cell Biol. 172:269–279. http ://dx .doi .org /10 
.1083 /jcb .200508091
Ungewickell, A., M.E.  Ward, E.  Ungewickell, and P.W.  Majerus. 2004. The 
inositol polyphosphate 5-phosphatase Ocrl associates with endosomes 
that are partially coated with clathrin. Proc. Natl. Acad. Sci. USA. 
101:13501–13506. http ://dx .doi .org /10 .1073 /pnas .0405664101
Vicinanza, M., A. Di Campli, E. Polishchuk, M. Santoro, G. Di Tullio, A. Godi, 
E. Levtchenko, M.G. De Leo, R. Polishchuk, L. Sandoval, et al. 2011. 
OCRL controls trafficking through early endosomes via PtdIns4,5P2-
dependent regulation of endosomal actin. EMBO J.  30:4970–4985. 
http ://dx .doi .org /10 .1038 /emboj .2011 .354
Walrant, A., D.S.  Saxton, G.P.  Correia, and J.L.  Gallop. 2015. Triggering 
actin polymerization in Xenopus egg extracts from phosphoinositide-
containing lipid bilayers. Methods Cell Biol. 128:125–147. http ://dx .doi 
.org /10 .1016 /bs .mcb .2015 .01 .020
Worby, C.A., and J.E. Dixon. 2002. Sorting out the cellular functions of sorting 
nexins. Nat. Rev. Mol. Cell Biol. 3:919–931. http ://dx .doi .org /10 .1038 /
nrm974
Yarar, D., C.M.  Waterman-Storer, and S.L.  Schmid. 2005. A dynamic 
actin cytoskeleton functions at multiple stages of clathrin-mediated 
endocytosis. Mol. Biol. Cell. 16:964–975. http ://dx .doi .org /10 .1091 /mbc 
.E04 -09 -0774
Yarar, D., C.M. Waterman-Storer, and S.L. Schmid. 2007. SNX9 couples actin 
assembly to phosphoinositide signals and is required for membrane 
remodeling during endocytosis. Dev. Cell. 13:43–56. http ://dx .doi .org /10 
.1016 /j .devcel .2007 .04 .014
Yarar, D., M.C. Surka, M.C. Leonard, and S.L. Schmid. 2008. SNX9 activities 
are regulated by multiple phosphoinositides through both PX and BAR 
domains. Traffic. 9:133–146. http ://dx .doi .org /10 .1111 /j .1600 -0854 .2007 
.00675 .x
 o
n
 O
ctober 2, 2017
jcb.rupress.org
D
ow
nloaded from
 
